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Abbreviations: 
BQ: 1,4-benzoquinone. 
Bn: benzyl. 
Boc: tert-butyloxycarbonyl. 
Cbz: benzyloxycarbonyl. 
m-CPBA: m-chloroperoxybenzoic acid. 
Cy: cyclohexyl.  
DABCO: 1,4-diazabicyclo[2.2.2]octane. 
DCE: dichloroethane. 
DCM: dichloromethane. 
DIAD: diisopropyl azodicarboxylate. 
DBU: 1,8-diazabicyclo[5.4.0]undec-7-ene. 
DEAD: diethyl azodicarboxylate. 
DMA: N,N-dimethylacetamide. 
DMF: N,N-dimethylformamide. 
DMP: Dess–Martin periodinane. 
DMSO: dimethylsulfoxide. 
DMEDA: N,N′-dimethylethylenediamine. 
Fmoc: fluorenylmethyloxycarbonyl 
HFIP: 1,1,1,3,3,3-hexafluoroisopropanol. 
HPBP: 2,2’.3,3’,5.5’-Hexaphenyl-(1,1’-biphenyl)-4,4’-diol. 
HRMS: high resolution mass spectrometry. 
h: hour. 
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IR: Infrared. 
MW: microwave. 
MS: mass spectrometry. 
NMR: nuclear magnetic resonance spectroscopy. 
o/n: overnight. 
PIDA: phenyliodine(III) diacetate. 
PIFA: [Bis(trifluoroacetoxy)iodo]benzene. 
Pd(dba)2: bis(dibenzylideneacetone)palladium(0). 
PIFA: [bis(trifluoroacetoxy)iodo]benzene. 
PTSA: p-toluenesulfonic acid monohydrate. 
TFA: trifluoroacetic anhydride. 
THF: tetrahydrofuran. 
TBAB: tetra-n-butylammonium bromide. 
TBAF: tetra-n-butylammonium fluoride. 
rt: room temperature. 
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Abstract: 
 
This thesis describes several approaches to the synthesis of dihydrooxazoles (oxazolines) by 
the cyclisation of unsaturated amides. 
The first major approach to the synthesis of substituted dihydrooxazoles is the CuI-catalysed 
cycloisomerisation of terminal propargyl amides. The reaction has been shown to have good 
substrate scope and experiments to delineate the mechanism have been performed. Substrates 
containing a benzylic methylene were oxidised to the ketone under the reaction conditions. 
 
The second major focus of this thesis is the cyclisation of N-alkenylamides catalysed by 
iodoarenes under oxidative conditions. Dihydrooxazoles were prepared by this route with a 
range of substitution patterns in good yields. 
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Introduction: 
A large number of oxazole, oxazoline and thiazole-containing natural products have been 
isolated from marine organisms, mainly sponges and ascidians, over the last two decades. The 
cytotoxic and antineoplastic activities that they exhibit, as well as the possibility of acting as 
metal ion chelating metabolites, have inspired a considerable amount of both structural and 
synthetic studies. In many cases, promising anti-tumour, antibacterial, anti-viral, anti-malaria 
and anthelmintic activities have been identified for these compounds.1-5 
As an example, the bistratamides (Figure 1) are a family of macrolactams isolated from 
Lissoclinum bistratum in the southern Philippines.6-8 Their interesting biological activities led 
to total syntheses of bistratamide family members.9,10 Bistratamides E to J (Figure 1) were 
isolated in the last few years and exhibit moderate cytotoxic activity against a human colon 
tumor (HCT-116) cell line.5  
There are several methods which can be used to form the oxazole ring or its derivatives. 
Hanzawa and co-workers have reported a method, where PIDA [phenyliodine(III) diacetate] 
(1.5 equiv) is used to form 2,5-disubstituted oxazoles via the oxidative cycloisomerisation of 
propargylamide derivatives (Scheme 1). Two sets of conditions were used in this reaction: 
AcOH as solvent at 90 °C, and HFIP (hexafluoroisopropanol) as solvent with the addition of 
AcOH (5 equiv) at room temperature.11  
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Figure 1: Bistratamides E-J 
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Scheme 1 
When they tried their two sets of conditions with internal alkynes, the oxazole ring was 
obtained only with the AcOH at 90 °C (Scheme 2). 
 
Scheme 2 
The mechanism of oxazole formation could proceed by two possible routes. Route a consists 
of (i) the cyclisation of 1 through the activation of the triple bond by PIDA, (ii) the formation 
of 6 by the deprotonation of 2 and the subsequent acetic acid elimination of 5, and (iii) the 
substitution of the phenyliodonium group in 6 by AcOH. In route b, the reaction of terminal 
alkynes with PIDA leads to the formation of the alkynyliodonium salts 3, which undergo ring 
closure to form intermediate 4. Proton transfer leads to 5 and the rest of the mechanism is the 
same as in route a (Scheme 3). 
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Scheme 3 
Propargylic alcohols and amides are used to produce oxazoles in the presence of PTSA (p-
toluenesulfonic acid monohydrate) as a catalyst (Scheme 4). This reaction is a one-pot PTSA-
catalysed propargylation/cycloisomerisation tandem reaction. PTSA acts as a bifunctional 
catalyst and effectively catalyses two reaction processes in a single reaction vessel under the 
same conditions. The reaction is completed rapidly under mild conditions and is tolerant of 
air, giving water as the only by-product.12 
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Scheme 4 
Another method to access oxazoles from propargylamides uses a Pd(II) catalyst in the 
presence of the oxidant 1,4-benzoquinone (BQ) (Scheme 5).13    
 
Scheme 5 
Beccalli et al. proposed the mechanism of this reaction to be an oxidative heterocyclisation 
(Scheme 6). The complexation of amide 7 with Pd(II) takes place on the C-C triple bond 
(intermediate 8) making it susceptible to nucleophilic attack. The role of the nucleophile is 
covered by the oxygen atom of the amide group, which gives rise to 5-exo-dig cyclisation to 
produce the oxazole skeleton by formation of the σ-alkenylpalladium complex 9. Ligand 
exchange with water, followed by reductive elimination and toutomerisation gives rise to 10. 
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At this point the oxidising system intervenes with a double role, namely (i) to reoxidise the 
Pd(0) species, formed at the end of the catalytic cycle, to the active Pd(II) and (ii) to promote 
the dehydrogenation of 10 giving 11. 
 
Scheme 6 
Several groups have reported that gold catalysts can cyclise amides onto alkynes.11 One of 
these reports states that oxazoles can be obtained by using catalytic gold(III) chloride 
(Scheme 7).14  
 
Scheme 7 
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In this reaction, the C-C triple bond is activated by cationic Au(III) coordination. This can 
accept the attack of the amide oxygen to afford a vinylgold intermediate. Alkene 
isomerisation forms the aromatic heterocycle and protonation of the Au-C bonds leads to the 
final product (Scheme 8).15 
 
Scheme 8 
A one-pot reaction starting from propargyl amine to prepare oxazoles has been reported by 
Müller and Merkul (Scheme 9). In this case, amidation followed by Sonogashira cross-
coupling and then acid mediated cycloisomerisation provides the products.16  
 
Scheme 9 
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Black and Arndtsen reported that Cu(I) and Zn(II) can be used to form secondary 
propargylamides from aldehydes, silylamide, acid chlorides, and alkynes (steps 1 and 2), but 
when catalytic NaH was added to the reaction mixture, cyclisation to the oxazole was effected 
(Scheme 10).17 
 
Scheme 10 
Bartoli et al. have published a rapid and efficient MW-assisted synthesis of oxazoles via the 
5-exo-dig cyclisation of functionalised N-propargyl carboxamides. After a variety of 
conditions were tested, it was observed that the addition of iodine to the reaction mixture gave 
higher selectivity and increased the yields: the resulting monomeric CeCl3·7H2O–NaI–I2 
complex is a strong Lewis acid (Scheme 11).18 
 
Scheme 11 
Hacksell and Nilsson prepared oxazoles by the cyclisation of α-arylsubstituted propargyl 
amides  using either sodium hydride (0.3-0.4 equiv) in tetrahydrofuran (method A) or 
powdered potassium carbonate (10 equiv) in acetonitrile (method B) (Scheme 12).19  
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Scheme 12 
The proposed mechanisms for the two methods are shown in Scheme 13. In mechanism A, 
the acetylenes rearrange to allenes and the central allenic carbon is attacked by the 
nucleophilic amide oxygen. In mechanism B, an acetylenic carbon is the electrophilic species. 
The authors stated that, the reaction is most likely going through mechanism A, because 1H 
NMR experiment demonstrated the presence of an allenic intermediate. 
 
Scheme 13 
Buchwald and Cheung reported a method for the synthesis of 2,5-disubstituted oxazoles via a 
stepwise Cu-catalysed sequence amidation of vinyl halides to form enamides, followed by a 
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Cu-catalysed oxidative cyclisation of the enamide intermediate promoted by potassium 
persulfate under ambient conditions (Scheme 14).20 
Scheme 14 
CuBr2 most likely serves as a single-electron oxidant, converting the electron-rich enamide 12 
to an enamide radical cation (Scheme 15, transformation i), which then cyclises to radical 
intermediate 13 (transformation ii). Subsequent oxidation of 13 by CuBr2 provides the 
oxazole (transformation iii). The reduced form of copper, CuBr, is then oxidised by K2S2O8 
and reacts with TBAB to regenerate the CuBr2 catalyst (transformation iv). 
 
Scheme 15 
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Stahl and Wendlandt prepared 2,5-disubstituted oxazoles by the cyclisation of enamides. The 
reaction required 2 equivalents of CuCl2 and 2 equivalents of N-methylimidazole (NMI) in 
1,4-dioxane under air at 140 °C (Scheme 16).21 
 
Scheme 16 
The authors speculated that this reaction involves initial CuII-mediated one electron oxidation 
of the enamide followed by loss of two protons and another electron to provide the oxazole 
product (Scheme 17). 
Scheme 17 
Wang and co-workers reported a one-pot method to prepare oxazoles, where CuI was used as 
catalyst (0.3 equiv), from benzylamine and benzil derivatives. The optimised conditions for 
the reaction required the addition of molecular sieves (4Å) and N,N-dimethylacetamide as 
solvent open to air at room temperature (Scheme 18).22 
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Scheme 18 
A plausible mechanism for the reaction is described as follows (Scheme 18): First, O2 
activates the Cu and 14 is formed from the condensation of benzyl and benzylamine. 
Enolisation provides 15 which undergoes an intramolecular cyclisation via the oxygen atom 
attacking the imine double bond to give the intermediate 16. After proton transfer, 17 is 
formed which is oxidised to 18 and the final product is released (Scheme 19). 
 
Scheme 19 
Strand and co-workers showed that the reaction between N-benzylpropargylamines and acid 
chlorides at elevated temperature (150 °C) using microwave irradiation can produce oxazole 
rings. This reaction required no solvent and just 15 minutes for complete conversion. Also, di- 
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and tri-substituted oxazoles can be prepared by using appropriate starting materials (Scheme 
20).23 
 
Scheme 20 
The mechanism of this reaction is illustrated in Scheme 21. First, the amide is formed and the 
proton lost from the nitrogen adds to the alkyne which enables the attack of oxygen of the 
amide to form the unstable five membered ring. Then, the benzyl is lost by the attack of Cl- 
and the alkene isomerises into the ring to provide the observed product.  
 
Scheme 21 
The Wang group has developed the first example of ZnI2 and FeCl3 promoted cyclisation of 
acetylenic amides to selectively achieve oxazolines and oxazoles respectively via a C-O bond 
formation (Scheme 22).24  
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Scheme 22 
A mechanism was proposed for the formation of oxazolines (23) and oxazoles (26) (Scheme 
23). First, ZnI2 coordinates with the triple bond of 19 which enhances the electrophilicity of 
the alkyne. Tautomerisation of the amido-imido intermediate 20 followed by regioselective 
intramolecular 5-exo-dig cyclisation via 21 gave the vinyl zinc intermediate 22 which on 
protonolysis with HI generated in situ, resulted in desired compound 23. In mechanism B, 
iron(III) is thought to acts as a Lewis acid that promotes the 5-exo-dig cyclisation of 
compound 19 via 24 to provide intermediate 25. Tautomerisation of intermediate 25 resulted 
in the formation of the required oxazole derivative 26. 
Scheme 23 
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Larock and Waldo have reported that methyl oximes can be cyclised to oxazoles via an 
electrophilic cyclisation strategy. They used iodine monochloride (ICl) in DCM at room 
temperature to effect this transformation (Scheme 24).25 
 
Scheme 24 
A possible mechanism was postulated as shown in Scheme 25. Coordination of the carbon-
carbon triple bond to the ICl or attack of the iodine cation on the triple bond can produce an 
iodonium intermediate. Nucleophilic attack of the oxygen of the methoxy group on to the 
activated iodonium intermediate can generate a five membered ring. Finally, facile removal of 
the methyl group via SN2 displacement by the chloride anion present in the reaction mixture 
can generate the final product and one equivalent of MeCl.26 
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Scheme 25 
Boshun Wan and his group have developed the base-catalysed cyclisation of N-sulfonyl 
propargylamides 27 to furnish various 5-(sulfonylmethyl)oxazoles 30. A number of bases 
were tested in an attempt to promote this process (PPh3, Et3N, DBU, DMAP, DABCO, LiOH, 
t-BuOLi, K2CO3, Na2CO3, Li2CO3, NaOAc, KOAc, CsOAc, K3PO4) in CH3CN. Among all 
the bases tested, only DBU selectively afforded the oxazole 30 after 7 hours using N-sulfonyl 
propargylamides 27 (Scheme 26).27  
 
Scheme 26 
  
 
21 
 
All of the other bases tested gave a mixture of the allenes 28 and the oxazoles or did not 
catalyse this rearrangement at all. Following this, they have shown that treating N-sulfonyl 
propargylamides with DABCO in DCM produce the corresponding allenylamides in high 
yields, and then reaction with DBU provides the oxazoles (Scheme 27).  
 
Scheme 27 
A mechanistic rationale is proposed for this transformation (Scheme 28). First, base-catalysed 
1,3-proton migration results in the formation of allenylamides 28, followed by nucleophilic 
attack of the oxygen at the allenyl carbon to give a zwitterionic intermediate 29. Finally 
rearrangement to oxazole 30 occurs via 1,4-sulfonyl shift. 
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Scheme 28 
As a continuation of their interest in the cyclisation of N-sulfonyl propargylamides, the Wan 
group tried a previous set of conditions (140 °C in DMF) to cyclise N-
sulfonylpropargylamides to obtain 4-sulfonylmethyloxazoles, but the reaction did not work 
(Scheme 29).28  
 
Scheme 29 
The major reason for this failure they attributed to the [3,3]-rearrangement of 
propargylamides not occurring under thermal conditions. To overcome this issue, they 
reasoned that activation of the alkyne moiety by a transition-metal catalyst (AgBF4) might 
promote the rearrangement of the propargylamide. In addition, they used a directing group 
(acyloxy) for its potential ability to coordinate with the transition-metal catalyst (Scheme 30). 
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Scheme 30 
They used different phenyl ring substituents (both electron-withdrawing and electron-
donating) and the oxazole rings were successfully obtained in good to excellent yields, but 
when alkyl substituents was used there was no product isolated. 
The authors postulated a mechanism for this reaction (Scheme 31). The first step is a π-
complex 32 formed between the alkyne moiety 31 and Ag(I) cation. The acyloxy group can 
also coordinate with Ag(I) to facilitate the subsequent transformation. Then, intramolecular 
nucleophilic attack of the carbonyl oxygen on to the amide via 6-endo-dig mode can lead to 
the formation of intermediate 33, which can collapse to allene intermediate 34. Then, 
nucleophilic attack of the nitrogen at the allenyl carbon can give zwitterionic intermediate 35 
which can rearrange to oxazole 36 via a sulfonyl shift by either intra- or intermolecular 
manner.  
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Scheme 31 
Inspired by the above proposed mechanism, propargylamide was converted in to 
allenylamide. Then, the same conditions were applied to the allenylamide, but no 4-
sulfonylmethyloxazole product was formed. Instead 5-vinyloxazole was isolated. In this 
transformation, the allene moiety was proposed to be activated by the Ag(I) cation, followed 
by the intramolecular nucleophilic attack of the oxygen atom at the amide moiety (Scheme 
32). Elimination of both the sulfonyl and acyloxy groups generated the final vinyloxazole 
product. 
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Scheme 32  
Another example of N-allenyl amides cyclisation has been presented by the Ma group. Here 
N-propargylamides were converted into N-allenyl amides in good to excellent yields with 
wide substrate scope using a Cy2NH/CuI protocol (Scheme 33).29 
 
Scheme 33 
In order to cyclise these N-allenylamides, they used a palladium catalyst and an aryl iodide in 
the presence of K2CO3 and DMF as solvent to form the oxazolines (Scheme 34). The 
mechanism of this reaction is proposed to proceed through the oxidative addition of 
palladium(0) to the aryl iodide 38 to form the organopalladium species 39 (Scheme 35). 
Reaction with N-allenyl amides gives intermediate 40 and oxygen attacks the allene to form 
the five-membered ring 41. Reductive elimination forms the desired product 42 and 
regenerates palladium catalyst 37. 
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Scheme 34 
 
Scheme 35 
Wan and co-workers reported a method for the cyclisation of N-sulfonyl propargylamides. 
They applied two sets of conditions both using N-iodosuccinimide (1.2 equiv) as an iodine 
source. They ran the first reaction in DCM at 40 °C to obtain polyfunctionalised oxazolidines 
which incorporated the succinimide. Whereas, running the reaction in DMF at room 
temperature led to formation of  iodoalkylidene dihydrooxazoles instead (Scheme 36).30 
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Scheme 36  
A plausible mechanism for the above two iodocyclisation reactions is depicted in Scheme 37. 
The reaction is initiated by the coordination of propargylamide with I+, thereby enhancing the 
electrophilicity of the alkyne moiety to generate intermediate 43. The activated triple bond 
then undergoes nucleophilic attack by the carbonyl oxygen to form intermediate 44 via a 5-
exo-dig cyclisation mode. Two different pathways are followed in the next reaction step on 
the basis of the choice of solvents. In DCM, the succinimide anion attacks the more 
electrophilic carbon of the iminium ion to furnish the final product (oxazolidine). In contrast, 
the succinimide anion traps the tosyl group of intermediate 44 to give the desired product 
(dihydrooxazole) when the reaction is carried out in the more polar solvent DMF. 
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Scheme 37 
These authors went on to demonstrate that iodoalkylidene dihydrooxazoles converted to 
oxazoles in the presence of one atmosphere of dioxygen (Scheme 38). This is the first report 
of the oxidation of iodoalkylidene dihydrooxazoles to the corresponding oxazoles. 
 
Scheme 38 
The mechanism of this oxidation is shown in the next scheme. The radical intermediate 44 
and an iodine radical are formed by homolytic cleavage of the C−I bond upon heating. 
Intermediate 44 can then quickly react with oxygen to give the peroxyl radical species 45, 
  
 
29 
 
which can be converted to the radical 46 via a six-membered-ring transition state. Radical 46 
can also be represented as its resonance structure 47, which is aromatic. Cleavage of the O-O 
bond leads to formation of the final product. The combination of iodine radicals and hydroxyl 
radicals results in the formation of HIO, which can easily decompose into oxygen, iodine, and 
water. 
Scheme 39 
On the basis of the above result, they combined the formation and oxidation of iodoalkylidene 
dihydrooxazole in one pot by adding dioxygen after the NIS-triggered cyclisation of 
propargylamides. Thus, the two-step one-pot reaction was accomplished successfully 
(Scheme 40).  
 
Scheme 40 
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Harmata and Huang stated that propargylic amides can be cyclised to 5-methyleneoxazolines 
in high yield at room temperature with a catalytic amount of silver hexafluoroantimonate 
(Scheme 41).31 
 
Scheme 41 
The possible mechanism of this reaction is shown in Scheme 42. In this reaction, cationic 
Ag(I) is thought to coordinate with the C-C triple bond. This activates it to intermolecular 
attack by the amide to afford the five membered ring intermediate. Finally, protonation of the 
C-Ag bond occurs to generate the product. 
 
Scheme 42 
Oxazoline can be formed by treating N-allylamide with PhI(OAc)2 (PIDA) in AcOH/Ac2O 
(5:1) at 50 ºC. When the reaction was left overnight some conversion to oxazoline had 
occurred, but there was still some starting material. By adding BF3·OEt2 (1.2 equiv) to the 
reaction mixture and conducting the reaction at room temperature, more starting material was 
converted to the product but full conversion was not achieved (Scheme 43).32 
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Scheme 43 
The expected mechanism for this transformation is shown in Scheme 44. It was suggested that 
BF3·OEt2 first converts PIDA to the more electrophilic aryliodonium ion 49. Then, iodonium 
ion 49 can interact with the alkene in 48 to generate either an activated olefin complex (50a) 
or a cyclic iodonium ion (50b). When R2 = H, attack by the amide in a 5-exo fashion affords 
primary alkyl iodane 51. Because of the superior leaving group ability of the iodine(III) 
nucleus, the nucleophilic attack by a second nucleophile (in this case acetic acid) is quite 
favorable. This SN2-like, bimolecular reductive elimination forms the oxazoline and liberates 
acetate and iodobenzene. The cyclisation reaction conditions were attempted with internal 
alkenes substrates, but these efforts resulted in complex product mixtures. As they stated, this 
is the result of the formation of carbocations via unimolecular reductive fragmentation of 
iodane 51 (R2 ≠ H). This again mentions the extreme leaving group ability of the iodine(III) 
nucleus. The authors stated that this mechanism is still under study. 
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Scheme 44 
Minakata’s group prepared oxazolines directly from unfunctionalised olefins and readily 
accessible amides using tert-butyl hypoiodite as a reagent in the presence of NaI and MeCN 
as solvent at room temperature (Scheme 45).33 
 
Scheme 45 
A mechanism was proposed for oxazoline formation with t-BuOI, generated in situ, initially 
reacting with the amide, not the olefin, to give the diiodinated amide. This occurs because a 
Lewis acid or UV light is known to be required for olefins to react with t-BuOI.34 When 
benzamide in CD3CN was treated with t-BuOCl and NaI, the 1H NMR spectrum showed a 
signal corresponding to the active hydrogens on the amide nitrogen that smoothly disappeared 
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and a signal corresponding to the tert-butyl group of t-BuOH appeared within one hour. From 
the NMR study, the generation of 52 might be suggested but there is no clear evidence at 
present. The active species 52 might function as an iodonium source, which reacts with 3-
hexene to generate the cyclic iodonium intermediate 53, followed by the addition of the 
counter amide anion, yielding adduct 54 which cyclised to oxazoline (Scheme 46). 
 
Scheme 46 
Wuts and co-workers obtained oxazolines by the cyclisation of amido alcohols using the 
Vilsmeier reagent in pyridine at room temperature. For most amido alcohol substrates they 
obtained both the desired oxazolines 55 as well as the chloride 56 (Scheme 47). Although an 
inconvenience, the chloride is readily converted to the oxazoline upon treatment with DBU.35 
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Scheme 47 
Zhdankin and co-workers have reported the first hypervalent iodine catalysed synthesis of 
isoxazoline derivatives using 3,5-Me2C6H3I (0.2 equiv) as catalyst. Oxone (2KHSO5. 
KHSO4.K2SO4) (3 equiv) was used as the oxidant, and the solvent was a mixture of 
1,1,1,3,3,3-hexafluoroisopropanol (HFIP) and MeOH and a small amount of water (10:10:1). 
The addition of a small amount of water is needed to increase the solubility of Oxone in the 
reaction mixture. They used alkenes (1.2 equiv) and aldoximes (1 equiv) as starting materials 
to get isoxazolines in moderate to excellent yields (Scheme 48).36 
 
Scheme 48 
After alkenes were successfully used, the authors tried to use alkynes instead of alkenes and 
applied the same conditions. The reaction worked to give isoxazoles in moderate to good 
yields (Scheme 49). 
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Scheme 49 
The proposed mechanism for this reaction is shown in scheme 50. First, the reaction of ArI 
with Oxone in aqueous HFIP generates the activate hypervalent iodine species 
hydroxyl(aryl)iodonium ion ArI(OH)+ 57, which reacts with aldoxime 58 to give hypervalent 
iodine species 59 through ligand exchange. Reductive elimination of ArI is taking place to 
generate nitrile oxide 60 which reacts with the alkene 61 or alkyne 62 to provide the 
corresponding isoxazoline 63 or isoxazole 64. The addition of HFIP to the reaction mixture is 
believed to generate the highly reactive electron-deficient hypervalent species 57, which 
speeds up the subsequent steps in the catalytic cycle, such as ligand exchange and oxidation 
of the aldoxime.  
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Scheme 50 
The Jin group established an efficient copper-catalysed cyclisation (10 mol% CuI) of steroidal 
acylaminoacetylenes to give the corresponding 11β-aryl-17,17-spiro[(4’H,5’-methylene) 
oxazole]-substituted steroids in moderate to good yields (Scheme 51).37 According to the 
report, the authors did not propose a mechanism for this reaction. 
 
Scheme 51 
The authors stated that the yield is dependent on the solvents used in the reaction. For 
example, when benzene at 80 °C was used just 30-35% product was isolated, but when they 
used a mixture of benzene and Et3N (1:1) at 90 °C 83-97% yield was obtained in 30 min. 
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Lowering the temperature to 40 °C gave the product in only 30-46% yield even after 24 h 
reaction time. Also, they tried the reaction with DMF and DMSO as solvents but there was no 
conversion in either case. 
Hashmi et al. have reported the cyclisation of nonterminal propargylic amides with a 
substituent on the propargyl group using gold(I) catalysis. They found that TMS protected 
propargylamine was the perfect building block for this approach. Then, they tested alkyl-
substituted propargylic amides, which were synthesised by deprotonation of N,N-
bis(trimethylsilyl)propargylamine with n-butyllithium and reaction with alkyl iodide to yield 
the substituted propargylamines 65. After the reaction with acid chloride, propargylic amide 
66 was obtained. Then, the gold catalyst and silver salt in THF were added to the propargylic 
amide 66 to produce a mixture of alkylideneoxazoline 67 (12-78%) and 1,3-oxazine 68 (10-
35%) (Scheme 52).38 
Scheme 52 
The oxazine 68 is formed via a 6-endo-dig cyclisation (path A), whereas the oxazoline 67 
originates from the 5-exo-dig cyclisation (path B) (Scheme 53). 
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Scheme 53 
Tungsten hexacarbonyl and molybdenum hexacarbonyl in the presence of DABCO (1,4- 
diazabicyclo[2.2.2]octane) have been used to cyclise N-propargyl amides to form oxazolines 
and oxazines (Scheme 54).39   
 
Scheme 54 
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Mechanistically, the alkynyl functionality of the propargylic amides 69 is activated by 
coordination with the W and Mo catalysts to generate π–alkyne complex 70, which is in 
equilibrium with the vinylidene complex 71 (Scheme 55). Intramolecular nucleophilic attack 
of the carbonyl oxygen on the amide of intermediate 70 via 5-exo or 6-endo mode followed 
by the protonation of the corresponding carbene compounds 72 or 73 produces oxazoline 74 
or oxazine 75. 
 
Scheme 55 
The Zhu group reported a route where 3,4,5-trisubstituted oxazolones can be synthesised by 
the reaction of N-alkynyl tert-butyloxycarbamates with aryl halides or related electrophiles. 
This reaction requires a catalytic amount of bis(dibenzylideneacetone)palladium(0) [Pd(dba)2] 
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and ligand (PPh3 or Xphos) in the presence of K2CO3 (1.5 equiv) in DMF at 70 °C (Scheme 
56).40 
 
Scheme 56 
The mechanism of this reaction is illustrated in the next scheme. The palladium intermediate 
76 formed by the oxidative addition of Pd(0) to the carbon-halide bond of R3X activates the 
alkyne to intramolecular attack to give  palladium species 77. In the final step, cleavage of the 
C-O bond of the tert-butyloxy group in intermediate 78 as well as reductive elimination 
results in the generation of 3,4,5-trisubsituted oxazolones with reformation of the palladium 
catalyst. 
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Scheme 57 
Ramesh et al. studied the effect of various bases and solvents on the cyclisation of O-
propargylcarbamates to 2-oxazolidinones, and they found that LiOH in DMF gave the best 
results (Scheme 58). Oxazolidinones have been found to have a large range of applications in 
organic synthesis as potential intermediates, as chiral auxiliaries, and in the preparation of 
organometallic reagents. Also derivatives have been shown to have antibacterial properties 
and hence these heterocyclic compounds are widely used in the pharmaceutical chemistry.41 
First, deprotonation occurs by LiOH (base) to leave a nucleophilic nitrogen, which attacks the 
triple bond and forms the five membered ring (Scheme 59).  
 
Scheme 58 
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Scheme 59 
Sanjaya and Chiba have reported the Cu-catalysed aminoacetoxylation of N-alkenylamidines 
to form imidazoles using PhI(OAc)2 as the oxygen source in the presence of a nitrogen ligand 
and a base. They examined several reaction conditions using different nitrogen ligands and 
bases, and found that using copper acetate Cu(OAc)2 (15 mol%) and 1,10-phenanthroline (15 
mol%) with K2PO4 (1 equiv) and DMF at room temperature provided the best yields (Scheme 
60).42  
 
Scheme 60 
Their proposed catalytic cycle for this aminoacetoxylation is outlined in Scheme 61. This 
process might be initiated by the formation of higher valent N-Cu(III) species 80 generated 
  
 
43 
 
from amidine 79, Cu(OAc)2, and PhI(OAc)2. The resulting N-Cu(III) species 80 undergoes 5-
exo aminocupration onto the alkenyl moiety to give organocopper(III) species 81. The 
subsequent reaction of 81 with an acetate ion, probably via an SN2 type substitution reaction, 
forms the C-O bond to afford 4-acetoxymethyl-4,5-dihydroimidazole 82 along with CuOAc 
83 that could maintain further catalytic turnover with PhI(OAc)2. 
 
Scheme 61 
The Wu group prepared imidazoles from propargyl amidines in excellent yields which were 
obtained under mild conditions by gold(I) catalysis via 5-exo-dig cyclisation. They envisioned 
that 2-fluoroalkyl imidazoles can be obtained in one pot from fluorinated imidoyl chlorides. 
With Ph3PAuCl/AgSbF6 as the catalyst and CH3CN as the solvent, an optimised yield of 89% 
was obtained when the reaction was carried out at 60 °C (Scheme 62).15 
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Scheme 62 
Upon amidation the cationic Au(I) is thought to coordinate with the C-C triple bond and 
activate it to  attack by the amidinonyl nitrogen to afford intermediate 84. Affected by the Rf 
group, 84 isomerises to the more stable imidazole 85 by a 1,3 proton shift. Finally, 
protonation of the C-Au bond leads to formation of the final product (Scheme 63). 
 
Scheme 63 
Peng and co-workers reported a copper-catalysed method for intramolecular N-arylation 
which provides the benzimidazole ring system. In this reaction, Cu2O (5 mol%) was used as 
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the catalyst, N,N′-dimethylethylenediamine (DMEDA) (10 mol%) as the ligand, and K2CO3 as 
the base in water at 100 °C (Scheme 64).43 
 
Scheme 64 
A proposed reaction mechanism for this intramolecular C-N bond formation from amidines to 
benzimidazole derivatives is shown in Scheme 65. This transformation presumably occurs 
through coordination of the imine functional group of amidine 86 to the Cu(I) centre followed 
by an intramolecular oxidative addition to the aryl halide, affording an intermediate complex 
87. The resulting complex 87 can react with base to form a Cu-N bond and afford the 
intermediate complex 88. This can undergo reductive elimination to form the coupled product 
89 and regenerate the catalytic copper species (path A). However, an alternative pathway via 
Cu-N bond formation in the first instance followed by oxidative addition cannot be 
completely ruled out (path B). 
  
 
46 
 
Scheme 65 
Ishihara and co-workers have developed an efficient molybdenum oxide catalysed 
dehydrative cyclisation of serine, threonine, and cysteine derivatives, which gives oxazolines 
and thiazolines in good yields. In particular, (NH4)6Mo7O24.4H2O and (NH4)2MoO4 showed 
excellent catalytic activities for the dehydrative cyclisation of serine and threonine derivatives 
(Scheme 66). This method can be applied to a wide range of complex substrates because the 
reaction proceeds under neutral conditions. The authors state that mechanistic studies and the 
application of this method to the synthesis of more complex natural products are in progress.44 
 
Scheme 66 
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Sanz-Cervera and co-workers reported a simple and efficient method to prepare 1,3-oxazoles  
and 1,3-thiazoles  using α-amido-β-ketoesters as starting materials (Scheme 67).45  This 
reaction was performed by treating the α-amido-β-ketoesters with triphenylphosphine, Ph3P, 
in the presence of iodine and triethylamine in dichloromethane at room temperature to give 
2,5-disubstituted oxazoles. Finally, the deprotection of the ester in position 4 of the oxazole 
ring through palladium-catalysed hydrogenolysis or hydrolysis with LiOH in THF/H2O gave 
the final oxazole compounds. 
 
Scheme 67 
Thiazoles are obtained from the same α-amido-β-ketoesters by reaction with Lawesson’s 
reagent in THF to produce 2,5-disubstituted thiazoles. Then the deprotection of the ester in 
position 4 of the thiazoles ring through palladium-catalysed hydrogenolysis or hydrolysis with 
LiOH in THF/H2O gave the final thiazole compounds (Scheme 68). 
Scheme 68 
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Batey and Evindar have reported that the copper-catalysed cyclisation of ortho-haloanilides is 
a generally applicable approach to benzoxazole ring formation. A reaction using 5 mol% of 
copper(I) iodide could be achieved with either 1,10-phenanthroline or N,N′-
dimethylethylenediamine as ligands, but 1,10-phenanthroline in general, showed greater 
substrate tolerance. The approach is readily applied to the synthesis of substituted 
benzoxazoles through incorporation of appropriately positioned substituents on the ortho-
haloanilide precursors. The reaction could also be adapted for benzothiazole formation using 
thioamide substrates (Scheme 69).46 
 
Scheme 69 
The most likely mechanism for the reaction involves the coordination of the amide group of 
90 with 91 to give 92, followed by an oxidative insertion to generate 93, and then a reductive 
elimination to release product 95 with concomitant regeneration of 91. The initial 
coordination to copper in 92 is supported by the lack of reactivity of the halo substituents at 
other positions in the ring under the copper catalysed conditions. The authors previous study 
on benzimidazole formation revealed similar selectivity for the copper-catalysed reactions, 
whereas the use of palladium catalysis led to competing debromination.47 The chelating 1,10-
phenanthroline ligand may serve to avoid multiple coordination of Cu by the amide substrate 
in 94 (Scheme 70). 
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Scheme 70 
Batey and Joyce have established a Pd/Mn based catalyst system for 2-aminobenzothiazole 
formation via an oxidative C-H functionalisation (Scheme 71). They used 
tetrakis(triphenylphosphine)palladium(0) [Pd(PPh3)4] as catalyst and manganese dioxide 
(MnO2) as co-oxidant under an oxygen atmosphere.48  
 
Scheme 71 
The mechanism of this cyclisation is still not fully understood, but they proposed a 
mechanism which suggests that a σ-bond metathesis mechanism occurs, wherein an anionic 
peroxo/peroxide-Pd bound ligand aids in proton abstraction (Scheme 72). 
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Scheme 72 
Bose and Idrees have reported a first preparation of benzothiazoles from thioformanilides by 
using Dess-Martin periodinane (DMP). This reaction is a one step process occurring in DCM 
at room temperature within 15 minutes (Scheme 73).49  
 
Scheme 73 
They proposed a plausible mechanism for this Dess-Martin periodinane promoted cyclisation 
reaction (Scheme 74). Arylthioformanilide 96 can exist as thioiminol 97; the latter reacts with 
DMP to produce thiyl radical 98 while iodine(V) is reduced to iodine(IV) at the same time. 
Subsequently, 1,5-homolytic radical cyclisation of 98 followed by aromatisation of radical 99 
gives 2-arylbenzothiazole 100. 
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 Scheme 74 
Previous work in the Moran group on the formation of carbocycles has shown that 
iodobenzene can catalyse the cyclisation of δ-alkynyl β-ketoesters under oxidative conditions 
to generate cyclopentane rings with high diastereoselectivity (Scheme 75). Under these 
conditions, iodobenzene is oxidised to an iodine(III) species which mediates this reaction. The 
products contain adjacent quaternary and tertiary stereocentres which are otherwise difficult 
to prepare.50 
 
Scheme 75 
Table 1 shows the derivatives which have been cyclised under these reaction conditions. The 
methyl and isopropyl ester derivatives of ethyl ester were cyclised, and the former resulted in 
a slightly diminished yield (entry 1, 54%- entry 2, 61%) whereas the latter only provided 37% 
yield (entries 1 and 3 vs 2). More importantly, the presence of the isopropyl ester reduced the 
diastereomeric ratio from 14:1 to 5:1. The increased steric bulk of the isopropyl ester is 
presumed to make the cyclisation event more difficult and reduce the facial selectivity. The 
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success of the cyclisation reaction was also found to be dependent on the alkyne substituent, 
with alkyl substituted benzene derivatives cyclising in low yield but with superior 
diastereoselectivity (>20:1 dr) (entries 4 and 5). However, the p-chlorobenzene substrate 
cyclised in a superior 88% yield with 14:1 dr (entry 6). 
 A substrate with an ethyl ketone substituent cyclized in a diminished yield and 
diastereoselectivity (entry 7). Substrates bearing p-nitrophenyl or p-methoxyphenyl 
substituted alkynes cyclised in only trace amounts. The reason for this is unknown. 
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Table 1 
Two plausible mechanisms are proposed for this cyclisation (Scheme 76). Both involve 
oxidation of the iodobenzene to a phenyliodine(III) species, which then either coordinates to 
the alkyne of the substrate (pathway A) or forms a ketoester α-I(III) species (pathway B). The 
former can then undergo intramolecular cyclisation to form a cyclopentane ring and 
vinyliodine(III) moiety II. Alternatively, the latter can undergo alkyne insertion to generate 
II. This species loses iodobenzene, thus regenerating the catalyst, and producing a vinylic 
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carbocation. This is trapped by water, and the resulting enol tautomerises to the observed 
tricarbonyl compound.  
 
Scheme 76 
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Aims and objectives: 
The overall aim of this project is to develop iodoarene catalysed methods to prepare 
heterocycles. 
Objective 1: To develop intramolecular amide-alkyne cyclisation reactions. 
Objective 2: To develop intramolecular amide-alkene cyclisation reactions. 
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Results and discussion: 
Building on the previous work using in-situ generated iodine(III) species to induce alkyne 
cyclisation processes (Scheme 75), the aim was to prepare alkynes bearing a pendant amide 
group and study the cyclisation of these compounds (Figure 2).  
 
Figure 2 
As shown, two possible amide isomers were envisaged, however the investigation 
commenced with amides derived from propargyl amine. In this way, it was surmised that 
oxazoline derivatives would be prepared. Accordingly, N-(prop-2-yn-1-yl)benzamide 101 was 
prepared from propargyl amine using a known procedure,51 and then N-(3-phenylprop-2-yn-1-
yl)benzamide (102) was synthesised from that amide through Sonogashira coupling using 
standard conditions (Scheme 77).52 
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Scheme 77 
The yield of isolated product was very low; however enough of compound 102 was in hand to 
attempt the desired cyclisation. In addition, it was assumed that modification of the 
Sonogashira coupling conditions would lead to superior yields in this process. 
In the event, treatment of amide 102 with the previously developed conditions did indeed lead 
to the desired ring formation (Scheme 78). Unfortunately, just 11% yield of isolated 
dihydrooxazole 103 was obtained.     
 
Scheme 78 
In an attempt to increase the yield of dihydrooxazole produced, a different iodoarene catalyst 
2,2'-diiodo-4,4',6,6'-tetramethylbiphenyl was prepared according to the method of Kita 
(Scheme 79).53 5-Iodo-m-xylene was used as the starting material, which was treated with 
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PIFA (1 equiv) in the presence of BF3.Et2O (2 equiv) at -78 °C. This compound has been 
shown to be a superior catalyst for the cyclisation of aryl alkynes and gives better yields 
compared to PhI (82% compared with 37%) (Scheme 80).54 
 
Scheme 79 
 
Scheme 80 
With this new biphenyl catalyst in hand, the cyclisation reaction was attempted again. This 
time a superior 33% yield was obtained, however the dihydrooxazole was not formed in this 
case. Instead, oxazole 105 was formed. In both of these reactions, the remainder of the mass 
balance was unreacted starting material (Scheme 81). 
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Scheme 81 
The reason for the over-oxidation to the aromatic heterocycle is unclear, however pleased 
with this proof of concept we decided to prepare a second substrate for investigation.  
Accordingly, N-(2,2-dimethylpropyne)benzamide (106a) was prepared from the 
commercially available amine in an analogous fashion to amide 101 (Scheme 82). 
 
Scheme 82 
Upon subjecting amide 106a to the previously employed Sonogashira reaction conditions, it 
was observed that none of the expected coupled product was formed (Scheme 83). 
 
Scheme 83 
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In the 1H NMR spectrum were two doublets at 4.25 and 4.74 ppm respectively and these 
cannot be due to the expected product or the starting material. After further investigations, 
4,4-dimethyl-5-methylene-2-phenyl-4,5-dihydro-oxazole (107a) was accepted as the product 
from this reaction but in low yield (20%). Note that the phenyl group from iodobenzene is not 
incorporated in to the product. 
Surprised and delighted by this unexpected reactivity, we decided to investigate this process 
in order to develop optimised conditions. The first question to answer was which metal salt 
was responsible for the cyclisation: Cu or Pd. Running the reaction with Pd(PPh3)4 but no CuI 
led to no product being formed. Eventually it was found that 10 mol% CuI in DCM at room 
temperature led to oxazoline formation providing 107a in 73% yield (Scheme 84).55 
 
Scheme 84 
In order to ascertain the effect of using different metal salts on this cyclisation, different 
catalysts were used instead of CuI. In the event, all of the copper and silver catalysts worked 
very well (Table 2). Stoichiometric quantities of sodium iodide and potassium t-butoxide 
were also tested and about 20% yield was obtained in both cases. However, it was decided to 
continue with CuI as it is cheap and easy to handle.  
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Catalyst Yield/%a 
AgOAc 99 
Cu(OAc)2 99 
Cu(OTf)2 99 
KOtBub  18 
NaIb  20 
CuSO4 99 
CuCl 99 
Table 2 (a) yield determined by 1H NMR analysis of the amide reaction mixture, (b) 1 equiv was used. 
With these optimised conditions in hand, various benzamide derivatives were prepared in 
order to investigate their cyclisations. Amides 106b, 106c, 106d were prepared in good 
yields, from the amines and acid chlorides as before (Scheme 85). Also, amides with 
cyclohexyl substrates were synthesised (106e, 106f, 106g, 106h) from the commercially 
available propargyl amines (Scheme 86).56  
 
Scheme 85 
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Scheme 86 
These amides were subjected to the developed reaction conditions and the five membered 
rings were formed in low yields (20-45%). It was decided to switch to DCE as the solvent so 
that reactions could be heated at 80 °C. Under these more forcing conditions, the cyclisations 
worked well and in higher yields (82-93%) (table 3).  
 
  
 
64 
 
 
  
 
65 
 
 
Table 3 
The reaction worked with electron-withdrawing and electron-donating aromatic substituents. 
However, the former generally took longer to react (up to 48 hours to reach completion for 
nitro substituents entries 3 and 7).   
In order to expand the substrates scope, heteroaromatic amides (106i to 106l) were prepared 
in an analogous fashion to the phenyl derivatives and in good yields (Scheme 87). 
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Scheme 87 
These indole, thiophene and furan derivatives were tested as starting materials using our 
standard reaction conditions. Thankfully, cyclisation was successful and the oxazoline rings 
were obtained in good yields (Scheme 88). 
 
Scheme 88 
Surprisingly, when N-(2-methylbut-3-yn-2-yl)-2-(thiophen-2-yl)acetamide 106k was 
subjected to the reaction conditions two new compounds were obtained (Scheme 89) in a ratio 
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of 2:1 (107k, 107k`). However, this reaction had been left for longer than standard (72 h 
instead of 24 h), and it seemed likely that the expected product 107k had been oxidised under 
the reaction conditions to generate the new compound 107k`. Therefore, the reaction was 
repeated and stopped after 24h. In this case, 107k was obtained as the only product in 72% 
yield. 
Scheme 89 
Intrigued by this methylene oxidation process, we decided to investigate this formation. To 
see if CuI was responsible for the ketone formation, two reactions were carried out with 107k. 
The first reaction was with CuI and the second reaction was without CuI. Both reactions were 
performed in DCE at 80 °C (Scheme 90). Analysis of the reaction mixtures showed that the 
oxidation only occurred in the reaction which contained CuI. 
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Scheme 90 
To test the generality of this process N-(2-methylbut-3-yn-2-yl)-2-phenylacetamide 106m was 
prepared from phenylacetic acid and 1,1-dimethylpropargyl amine via the acid chloride 
(Scheme 91). 
 
Scheme 91 
 The cyclisation of 106m was attempted with our standard conditions. In this case, 
intermediate 107m` could not be isolated, and the oxidised product 107m was formed in 71% 
yield (Scheme 92). 
 
Scheme 92 
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The CuCl-catalysed oxidation of diarylmethanes to benzophenones has been reported 
however an oxygen atmosphere and a dioxyl radical mediating agent was necessary for 
efficient conversion (Scheme 93).57 
 
Scheme 93 
To further explore the substrate scope of the cyclisation, 1-(phenylethynyl)cyclohexan-1-
amine 108 was prepared from 1-ethynylcyclohexan-1-amine through Sonogashira coupling 
using standard conditions.52 Then, this amine was converted to the  amide using standard 
conditions to give 109 in 89% (Scheme 94).56 
 
Scheme 94 
The cyclisation of this substrate was attempted using our conditions (Scheme 95), but there 
was no product obtained according to 1H NMR analysis. This result suggests that starting 
materials containing an internal alkyne do not undergo cyclisation using these conditions. 
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Scheme 95 
One possible mechanism of this reaction is shown in Scheme 96. In this case, cationic Cu(I) 
coordinates with the C-C triple bond to activate it to nucleophilic attack. Then, cyclisation can 
occur by attack of the C-C triple bond by the amide oxygen to afford the five membered ring 
intermediate upon loss of a proton. Finally, protonation can occur to generate the final 
product. 
 
Scheme 96 
In order to obtain evidence for the above mechanism, 106a was treated with D2O in the 
presence of K2CO3 in MeCN to prepare the corresponding deuterium substrate (Scheme 97).58 
The D incorporation was 93% at alkyne and 94% at the amide. 
 
Scheme 97 
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The deuterated compound was treated with HCl in order to dedeuterate the amide and 
protonate it. The target deuterated compound 106n was synthesised in 66% yield (Scheme 
98).  
 
Scheme 98 
When 13C NMR was run there was no signal for the two alkyne carbons but when HMBC 
NMR experiment was run a coupling could be seen between methyl carbon and the alkyne 
carbon (around 86 ppm) which is closer to it (as shown in the diagram). These carbon signals 
are known to be weak due to D splitting.58 
 
Figure 3 
106n was subjected to the standard reaction conditions with CuI in DCE, which led to 
formation of the five membered ring (Scheme 99). In the event, three compounds were 
observed by 1H NMR analysis of the crude reaction mixture in a 3 : 1 : 1 ratio. The major 
product was 107a with the two mono-deuterated compounds 107na and 107nb formed in 
equal and minor amounts. 
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Scheme 99 
The product mixture obtained from the deuterium labelling experiment could not be resolved 
with pure components. However, 1H NMR spectroscopy revealed a pair of mutually coupled 
doublets (J = 2.9 Hz) of δ = 4.26 ppm and δ = 4.74 ppm referred to the non-deuterated 
product 107a (Figure 3). At slightly high field than each of the forgoing doublets was a less 
intent singlet which was presumed to arise from each of the mono-deuterated species 107na 
and 107nb. 
 
Figure 4 
These results along with the inability of 109 to cyclise led us to postulate that the mechanism 
proceeds through formation of a copper acetylide followed by cyclisation, proton transfer and 
protonation to regenerate the Cu(I) catalyst (Scheme 100). 
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Scheme 100 
The Cu-catalysed azide alkyne cycloaddition reaction (click reaction) is believed to proceed 
through copper acetylide formation and cyclisation.59 However, we cannot completely rule out 
the alternative mechanism of the Cu(I) catalyst activating the alkyne for cyclisation with the 
CuI also causing H/D scrambling before cyclisation. Our attempts to alkylate the Cu 
intermediates with iodomethane or allyl bromide were unsuccessful. 
To further investigate the substrate scope and the structural requirements for cyclisation three 
more compounds were prepared from propargyl amines and acid chlorides (101, 106o, 106p) 
(Scheme 101) 
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Scheme 101 
These compounds were tested as starting materials using our standard reaction conditions in 
order to cyclise them but without success (Scheme 102).   
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Scheme 102 
In order to develop a general route to prepare more substituted amides for use in this 
cyclisation, we took inspiration from the method reported by Larsen and co-workers (Scheme 
103).60 In this case terminal alkynes, aldehydes and amines were combined under Cu catalysis 
to generate propargyl amine products. However, the use of amides as the nitrogen component 
is unknown, and this is what we required for our reaction.  
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Scheme 103 
The mechanism of this reaction is shown in Scheme 104.61 First, copper coordinates to alkyne 
110 to form π-complex 111, this increases the acidity of the acetylenic hydrogen which is 
removed by the amine (or more probably by the hemiaminal intermediate resulting from the 
reaction between the amine 112 and the aldehyde 113) to give copper acetylide 114. The 
proton assisted condensation between the amine 112 and the aldehyde 113 generates a 
molecule of water and the iminium complex 115, which reacts with the copper acetylide 114 
to afford the desired propargylamine 116 and regenerate the Cu(OTf)2 catalyst.  
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Scheme 104 
Accordingly, we began by mixing benzamide with benzaldehyde and phenylacetylene along 
with Cu(OTf)2 in order to prepare N-(1,3-diphenylprop-2-yn-1-yl)benzamide (Scheme 105). 
However, when the 1H NMR spectrum of the crude reaction mixture was obtained there were 
no signals matching the expected compound. Instead, a mixture of two compounds was 
evident which were separated by column chromatography and identified as 117 and 118 in 
42% and 45% yields respectively. 
  
 
78 
 
 
Scheme 105 
Product 117 was suspected to be the result of the reaction between benzaldehyde with 
phenylacetylene, which is a known process.62 To confirm this hypothesis, we ran the reaction 
using just these two starting materials and E-chalcone was indeed formed (Scheme 106).  
 
Scheme 106 
Subsequently, attempts were made to convert 117 to 118 by treatment with benzamide under 
Cu catalyst conditions, but no reaction was evident. Therefore, it was presumed that an 
alternative pathway was necessary for formation of 118. In an attempt to optimise reaction 
conditions to prepare 118 selectively we ran several reactions with various catalysts and 
solvents (table 4). 
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Entry Catalyst 10 mol% Solvent Temperature/°C Yield/% 
1 CuI Toluene 100 N.R 
2 Cu(OAc)2 Toluene 100 N.R 
3 AgOAc
 
Toluene 100 N.R 
4 AgOTf
 
Toluene 100 N.R 
5 AgSbF6 Toluene 100 N.R 
6 Bi(OTf)3 Toluene 100 N.R 
7 CsCl2 Toluene 100 N.R 
8 TfOH Toluene 100 N.R 
9 p-TsOH. H2O Toluene 100 N.R 
10 TFA Toluene 100 N.R 
11 TFA 1,4-dioxane 100 N.R 
12 TFA DMF 160 N.R 
13 Cu(OTf)2 DMSO 188 N.R 
14a Cu(OTf)2 DCE 80 117: 16%, 118: 20% 
Table 4  
We ran 14 reactions using different catalysts and solvents (Table 4). Different Cu and Ag salts 
were used with the same conditions but none of them led to product formation (entries 1-5). 
Then, bismuth and caesium catalysts were tested (entries 6 and 7), but no product was 
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obtained. Different Brönsted acids were then tested using the same conditions (entries 8-10), 
and with TFA in different solvents (entries 11 and 12), but unfortunately none of these 
conditions worked. The reaction was attempted again with Cu(OTf)2 as catalyst but using 
DMSO (entry 13) and DCE (entry 14) as solvents, but unfortunately only the latter set of 
conditions worked giving the same compounds but in lower yields compared to the original. 
At this point, the study of this process was abandoned. 
In a further attempt to increase the substrate scope of our CuI-catalysed cyclisation, we 
decided to prepare the thioamide derivatives of some of the amides we had with the intention 
of cyclising these. However, when 106a was reacted with Lawesson’s reagent in toluene,63 
4,4-dimethyl-5-methylene-2-phenyl-thiazole (119a) was obtained directly without 
requirement for any catalyst. The same conditions were applied to some other benzamides and 
heterocycles 119b and 119c were isolated (Scheme 107). 
 
Scheme 107 
 In a further attempt to isolate the thioamide analogue, tetraphosphorus decasulfide in pyridine 
(P4S10 in pyridine) was prepared (Scheme 108),64 and added to 106a but no reaction took 
place. 
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Scheme 108 
The proposed mechanism of the cyclisation with Lawesson’s reagent which is in equilibrium 
with a more reactive dithiophosphine ylide in solution is shown below (Scheme 109). The 
reaction with a carbonyl gives rise to a thiaoxaphosphetane intermediate. The driving force is 
the formation of a stable P=O bond in a cycloreversion step that resembles a portion of the 
mechanism known for the Wittig reaction. Then the cyclisation occurs to give the final 
product. 
 
Scheme 109 
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In an attempt to convert the alkene to an alkane hydrogenation of 107e was attempted using 
Pd/C as catalyst under a hydrogen gas atmosphere (Scheme 110). However, instead of the 
expected product, ring opened 120 was isolated in 53% yield.  
 
Scheme 110 
The proposed mechanism of this reaction is shown in Scheme 111. The first step is hydro-
palladation of the alkene to form intermediate 121 followed by β-O elimination to give 
intermediate 122. Reductive elimination of intermediate 122 and then tautomerisation 
provides intermediate 124. Then, hydro-palladation can take place again to form intermediate 
125 followed by reductive elimination to afford product 120. 
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Scheme 111 
The cyclisation of amide 106a using other sources of iodine was also considered. 
Consequently, 106a was reacted with NIS (N-iodosuccinimide) and 5-(iodomethylene)-4,4-
dimethyl-2-phenyl-4,5-dihydrooxazole 126 was formed in excellent yield (Scheme 112). 
However, it was decided not to continue this avenue of research. 
 
Scheme 112 
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Satisfied with the mixed success obtained with the alkyne substrates, the development of 
catalytic conditions for the cyclisation of related alkene substrates was envisaged using in-situ 
generated iodine(III) species (Scheme 113). In this case, the corresponding alcohol would be 
formed. 
 
Scheme 113 
Catalytic hypervalent iodine reactions with alkene substrates are rare, perhaps due to the ease 
of oxidation of alkenes. For example, Fujita and co-workers reported that the use of 
iodosylbenzene (PhIO) and BF3.OEt2 with carboxylate starting materials provided a mixture 
of tetrahydrofurans (49%) and ketones (14%) (Scheme 114).65 
Scheme 114 
Repeating this reaction with a chiral catalyst, which was prepared by the reaction of 2-
iodophenol with methyl lactate, resulted in just the furan ring product being formed. 
Importantly, an 18:82 e.r. was obtained with this catalyst (Scheme 115).66 
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Scheme 115 
Another recent example employed N-allylamide as the starting material. This was 
successfully cyclised to the oxazoline ring using PhI(OAc)2 (PIDA) in AcOH/Ac2O (5:1) but 
required the addition of BF3·OEt2 (1.2 equiv) for the best result (Scheme 116). Only terminal 
alkenes were cyclised in this report and only five membered rings were formed.67 
 
Scheme 116 
Previous work and unpublished in the Moran group has led to the development of reaction 
conditions to cyclise alkene substrates using PhI as the catalyst and Selectfluor as the oxidant 
in the presence of TFA in MeCN at room temperature (Scheme 117).  
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Scheme 117 
With a desire to develop catalytic conditions for the cyclisation of allylamides, N-
allylbenzamide 127a was prepared from commercially available allylamine in an analogous 
fashion to the previous amide (Scheme 118). 
 
Scheme 118 
With 127a in hand, the cyclisation was attempted using PhI (0.2 equiv), TFA (2 equiv) and 
Selectfluor (2 equiv) in MeCN. Excitingly, the expected product (2-phenyl-4,5-
dihydrooxazol-5-yl)methanol 128a was obtained but in just 6% yield (table 5 entry 1). It has 
been found that the work up for this reaction is crucial to obtain the alcohol product. In the 
workup, NaOH (1M) is added to the reaction mixture which is then extracted with DCM. In 
order to try to increase the yield above 6%, different iodoarene catalysts were used instead of 
iodobenzene. Accordingly, when 3-iodoanisole was used the yield was increased up to 9% 
(entry 2) and the yield was doubled to 13% when 5-iodo-m-xylene was used (entry 3). 
However, using 2-iodoanisole the yield was raised to a much more satisfactory 62% (entry 4). 
Then the effect of changing the oxidant was investigated, so m-CPBA was used and Oxone 
but no product was obtained in either case (entries 5, 6 and 7). We ran a reaction without any 
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iodoarene catalyst to see it Selectfluor was itself responsible for cyclisation but the starting 
material was recovered unconverted (entry 8).  
 
Entry ArI Oxidant Yield/% 
1 PhI Selectfluor 6 
2 3-iodoanisole Selectfluor 9 
3 5-iodo-m-xylene Selectfluor 13 
4 2-iodoanisole Selectfluor 62 
5 2-iodoanisole m-CPBA - 
6 2-iodoanisole Oxone - 
7 PhI m-CPBA - 
8 - Selectfluor - 
Table 5 
Following this success, various allylamide derivatives 127b -127h were produced in similar 
fashion (Scheme 119). 
 
Scheme 119 
With these substrates in hand, the cyclisation was attempted and the reaction worked with 
electron-withdrawing and electron-donating aromatic substituents (table 6 entries 1-3). The 
furan substrate was cyclised in 79% to provide the interesting biheterocyclic compound 128e 
(entry 4). As discussed above, the cyclisation of di, tri and tetra-substituted alkenes was an 
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important goal in this project. Therefore, the reaction was attempted using 1,1-disubstituted 
alkene 127f to provide product 128f in 81% (entry 5).  However, the cyclisation of tri-
substituted alkene and a furan did not work (entries 6 and 7). 
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Table 6 
 O-Toluic acid and phenylacetic acid were converted to amides 129a and 129b through this 
route (Scheme 120). Then, the cyclisation reaction was attempted to cyclise these amides to 
the corresponding rings. In the event, the reaction worked with 129a to provide compound 
130 in 72% (Scheme 121), however the cyclisation conditions failed with amide 129b. 
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Scheme 120 
 
Scheme 121 
Compound 131 was prepared through the esterification of cis-2-amino-3-cyclopentene-1-
carboxylic acid hydrochloride,68 followed by amidation using 4-methoxybenzoyl chloride to 
provide the amide product in 81% yield. Then, the cyclisation reaction was attempted using 
our standard conditions to give product 132 in 53% (Scheme 122). We were pleased to find 
that only one diastereomer of product was evident in the NMR spectrum to the crude reaction 
mixture. 
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Scheme 122 
Amide 133 was prepared from α-methylstyrene through four steps. The first step was 2-
methylallylbromide synthesis by the reaction of α-methylstyrene with N-bromosuccinimide in 
CCl4 under reflux.69 (3-bromoprop-1-en-2-yl)benzene was treated with phthalimide and 
K2CO3 in DMF at 60 °C to provide the phthalimide compound, which was cleaved by 
hydrazine hydrate in petroleum ether  (40-60 °C) to obtain the free amine. The amine was 
converted to the amide by addition of the acid chloride to provide the product in 69% yield. 
Finally, the cyclisation reaction was attempted using our conditions but no reaction occurred 
and the starting material was lost (Scheme 123). The presence of the phenyl group, 
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Scheme 123 
Also, amide 134 was readily prepared from the amine, however when the cyclisation reaction 
was attempted using our conditions there was no product obtained and the starting material 
was destroyed (Scheme 124). It is unclear as to what happened but the presence of the second 
alkene moiety must be incompatible with the reaction conditions. 
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Scheme 124 
Muñiz and co-workers recently reported a method, where indole derivatives can be 
synthesised through hypervalent iodine(III) mediated oxidation of 2-vinyl anilines.70 They 
tested different aryl iodine reagents [PhI(OAc)2, PIFA, Ph(OH)(OTs), PhIO] to find that, 
using PhIO (1.1 equiv) and 2,4,6-triisopropylbenzenesulfonic acid as oxidant in chloroform at 
room temperature gave the best yield (Scheme 125). They demonstrated that the reaction is 
successful for a range of substituted anilines. 
 
Scheme 125 
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Based on this report, it was proposed to test our cyclisation conditions with this substrate to 
determine whether either the indole ring or oxazine ring would form (Scheme 126). 
Accordingly, we prepared N-(2-vinylphenyl)benzamide 135 from 2-vinylaniline in 84% yield 
(Scheme 127).70  
 
Scheme 126 
 
Scheme 127 
Then, the cyclisation reaction of 135 was attempted using our standard conditions. 
Unfortunately, there was no sign of either oxazoline or indole ring by 1H NMR analysis of the 
crude mixture, and we recovered the starting material.  
The proposed mechanism for our catalytic cyclisation reaction is shown in Scheme 128. 
Initially, 2-iodoanisole must be oxidised to an iodine(III) species, which activates the double 
bond to attack from the amide oxygen. This leads to five membered ring formation. Then, the 
iodine(III) must be displaced by TFA or a trifluoroacetate anion to form an unstable product, 
which by base work up is converted to the stable final compound.  
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Scheme 128 
In order to extend the scope of the reaction to include the formation of larger ring sizes, 
syntheses of homopropargyl amides, bishomopropargyl amides etc. were required. Another 
member of the Moran group (Somaia Kamouka) prepared homopropargyl amides in an 
analogous fashion to the above and these cyclised to oxazin in good yields (Scheme 129). 
However, bishomopropargyl amines are not commercially available and a new synthetic 
approach was required. 
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Scheme 129 
According to Trudell and Apsunde’s report, primary alcohols can be reacted with primary 
amines in the presence of an iridium catalyst using microwave irradiation to form amides 
(Scheme 130). 71 We wanted to use this method in order to prepare longer chain starting 
materials. 
 
Scheme 130 
The proposed mechanism of this reaction is showed in Scheme 131. The first step of the 
reaction involves catalytic oxidation of the alcohol to the corresponding ketone 138 and 
iridium hydride 137.72 Intermediate 138 reacts with the primary amide to afford amide 139. 
Then the addition of the iridium hydride 137 to the C=N bond of 139 can occur to give an 
amido iridium species 140. This species 140 can react with an alcohol to give the product 141 
and regenerate the alkoxo iridium complex 136.73 
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Scheme 131 
Accordingly, we mixed 4-methylbenzamide (1 equiv) and 5-hexen-1-ol (3 equiv) under the 
reaction conditions, but unfortunately there was no sign of the desired product in the crude 
reaction mixture (Scheme 132). The original report did not include examples of alcohols with 
alkenes or alkynes in them. Possibly this is the limitation of this method. 
 
Scheme 132 
Moving forwards, we decided to follow a longer, but more precedented, synthetic sequence to 
prepare the desired compound (Scheme 133).74 In this method, they used an alcohol (1 equiv) 
as the starting material and reacted with phthalimide, triphenylphosphine (PPh3) and 
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diisopropyl azodicarboxylate (DIAD) in THF to provide the phthalimide product. This was 
cleaved to form the amine by adding hydrazine hydrate.  
 
Scheme 133 
We used the same alcohols which they used in this procedure (4-penten-1-ol and 4-hexen-1-
ol) and the corresponding phthalimides were successfully obtained. However, when these 
phthalimdes were reacted with hydrazine hydrate, there was no sign of the desired amines in 
the crude reaction mixture and the phthalimide compounds were not recovered (Scheme 134). 
 
Scheme 134 
In a further attempt to expand the scope of this process, we tried to prepare the thioamide 
analogues by the reaction of allylamides (127b, 127c) with Lawesson’s reagent. 
Unfortunately we could not get a clean product to apply our cyclisation conditions. 
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Conclusion: 
 
The preparation of substituted dihydrooxazole rings through two different methods has been 
demonstrated. The first one required a catalytic amount of CuI to cyclise propargyl amides to 
dihydrooxazoles. Mechanistic information has been obtained and concomitant benzylic 
oxidation has been observed in appropriate compounds. This reaction is efficient, easy to 
carry out and has good scope. In addition, Lawesson’s reagent has been shown to effect direct 
cyclisation of propargyl amides to the analogous dihydrothiazoles. 
The second method presented is the cyclisation of N-alkenylamides using catalytic quantities 
of iodoarenes. 2-Iodoanisole has proven to be a superior catalyst than the other iodoarenes 
tested in this process. Mono- and disubstituted alkenes have been cyclised to the 
corresponding five membered rings in good yields. 
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Future work:  
 
For future work, the cyclisation of different starting materials to prepare further heterocyclic 
products using 2-iodoanisole as the catalyst is envisaged. For example, the cyclisation of a 
propargylamide to the corresponding five membered ring has already been achieved but in 
low yield. It is expected that the use of 2-iodoanisole instead of iodobenzene will lead to a 
superior yield for this process. Also, the cyclisation of carbamates is expected to produce 
oxazolidinones (Scheme 135). 
 
Scheme 135 
In addition, N-alkenylamidines could be used as starting materials to prepare substituted 
imadazole rings in an analogous manner (Scheme 136). 
 
Scheme 136 
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Experimental part: 
General. 1H NMR spectra were recorded at 400 MHz. Chemical shifts are reported in ppm 
from tetramethylsilane with the solvent resonance as the internal standard (CDCl3: 7.26 ppm). 
Data are reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, 
t = triplet, q = quartet, br = broad, m = multiplet), and coupling constants (Hz). 13C NMR 
spectra were recorded with complete proton decoupling. Chemical shifts are reported in ppm 
from tetramethylsilane with the solvent as the internal standard (CDCl3: 77.4 ppm). Mass 
spectrometry (m/z) was performed in ESI mode, with only molecular ions being reported. 
Infrared (IR) spectra Ȟmax are reported in cm-1. Bands are characterised as broad (br), strong 
(s), medium (m) and weak (w). All generally available reagents were purchased from Sigma-
Aldrich, Fisher and Acros and were used as supplied without further purification. Two grade 
sizes of silica gel were used in column chromatography (35-75 ȝm, 63-200 ȝm). 
N-(Prop-2-ynyl)benzamide, 101:75 
 
In a round bottom flask propargyl amine (0.58 mL, 9.1 mmol, 1 equiv) was dissolved in DCM 
(10 mL). Then, benzoylchloride (2 mL, 17.2 mmol, 1.89 equiv) and triethylamine (2.54 mL, 
18.2 mmol, 2 equiv) were added. The mixture was stirred and left overnight under a nitrogen 
atmosphere. A saturated solution of NaCl was added (10 mL) and the mixture extracted with 
DCM (10 mL x 2); the organic layers were combined and dried with anhydrous magnesium 
sulfate, filtered and concentrated under vacuum to provide 101 (1.2 g, 83%) as a white solid. 
Melting point: 109-112 °C. 
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IR(neat): 3288 (m), 3058 (w), 1648 (m), 1536 (s), 1487 (m) cm-1. 
1H NMR (400 MHz, CDCl3): δ 2.53 (1H, s), 4.62 (2H, dd, J =  2.6. 5.7 Hz), 6.79 (1H, s), 7.48-
7.55 (2H, m), 7.66-7.71 (1H, m), 7.79-7.83 (2H, m).  
13C NMR (100 MHz, CDCl3): δ 29.8, 71.9, 79.5, 127.0, 128.6, 131.8, 133.7, 167.1. 
MS:  m/z (M + 23) 182.1 
HRMSμ m/z calc’d for [M + Na]+ C10H9NNaO 182.0576, found 182.0576. 
N-(3-Phenylprop-2-yn-1-yl)benzamide, 102: 
 
N-(prop-2-ynyl)benzamide 101 (0.96 g, 6 mmol, 1 equiv) was dissolved in Et3N (25 mL), 
then PhI (0.67 mL, 6 mmol, 1 equiv), CuI (114 mg, 0.6 mmol, 0.10 equiv) and Pd(PPh3)4 (35 
mg, 0.03 mmol, 0.005 equiv) were added. The mixture was stirred overnight under nitrogen 
atmosphere. The mixture was concentrated and purified by flash chromatography (5:1) 
(petroleum ether 40-60 /EtOAc on silica) to give the product 102 as brown solid (0.097 g, 
10%). 
Melting point: 99-101 °C. 
IR(neat): 2309 (w), 2924 (w), 2361 (w), 1639 (m), 1529 (m) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 4.50 (2H, d, J = 5.1 Hz), 6.36 (1H, br), 7.31-7.37 (3H, m), 
7.43-7.47 (4H, m), 7.50-7.54 (1H, m), 7.82 (2H, d, J = 8.1 Hz).  
13C NMR (100 MHz, CDCl3): δ 31.0, 84.0, 85.0, 122.8, 127.4, 128.5, 128.7, 128.9, 129.0, 
132.2, 134.3, 167.4. 
MS:  m/z (M + 1) 236.1.  
HRMSμ m/z calc’d for [M + H]+ C16H14NO 236.1070, found 236.1073. 
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Phenyl(2-phenyl-4,5-dihydrooxazol-5-yl)methanone, 103: 
 
A flask was charged with N-(3-phenylprop-2-yn-1-yl)benzamide, 102 (40 mg, 0.17 mmol, 1 
equiv), iodobenzene (3.8 µL, 0.034 mmol, 0.2 equiv), p-toluenesulfonic acid (97 mg, 0.51 
mmol, 3 equiv), m-chloroperbenzoic acid (88 mg, 0.51 mmol, 3 equiv) and acetonitrile (1 
mL) and stirred at room temperature under an air atmosphere overnight. The reaction mixture 
was quenched by addition of sat. aq. sodium thiosulfate solution, extracted with 
dichloromethane, and washed with sat. aq. sodium bicarbonate solution. The organic layer 
was dried over magnesium sulfate, filtered and concentrated. The residue was purified by 
flash chromatography (20:1 petroleum ether 40-60 °C/ethyl acetate) to give 103 as a white 
solid (0.0048 g, 11%). 
Melting point: 115-118 °C. 
IR(neat): 2922 (w), 1712 (s), 1650 (s), 1447 (s), 1257 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 4.28 (1H, dd, J = 3.4, 7.8 Hz), 4.45 (1H, dd, 3.5, 11.3 Hz), 
5.86 (1H, dd, J = 5.3, 11.1 Hz), 7.40-7.54 (5H, m), 7.62-7.66 (2H, m), 7.98-8.0 (3H, m). 
13C NMR (100 MHz, CDCl3): δ 59.5, 80.6, 128.0, 129.3, 129.4, 129.8, 130.0, 132.7, 134.9, 
135.0, 165.1, 195.9.  
MS:  m/z (M + 1) 252.1 
HRMSμ m/z calc’d for [M + H]+ C16H13NO2 252.1019, found 252.1026. 
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2,2’-Diiodo-4,4’,6,6’-tetramethylbiphenyl, 104:76 
 
In a round bottom flask 5-iodo-m-xylene (0.29 mL, 2 mmol, 1 equiv) was dissolved in dry 
DCM (5 mL). This mixture was added dropwise to a solution of PIFA (0.43 g, 1 mmol, 0.5 
equiv) and BF3.Et2O (0.25 mL, 2 mmol, 1 equiv) under nitrogen atmosphere at -78 °C. The 
reaction was stired at same tempreture for 3 h, and then the mixture was quenched with 
saturated aqueous NaHCO3, and extracted with DCM (10 mL x 2). The combined organic 
layers were washed with brine and dried with anhydrous magnesium sulfate, filtered and 
concentrated under vacuum to provide 104 as a white solid (0.043 g, 5%). 
Melting point: 115-118 °C. 
IR(neat): 3018 (w), 2910 (w), 1625 (m), 1566 (s), 1056 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.97 (6H, s), 2.33 (6H, s), 7.10 (2H, s), 7.63 (2H, s).   
13C NMR (100 MHz, CDCl3): δ 21.1, 21.8, 101.4, 131.4, 137.5, 137.6, 139.6, 144.9. 
HRMSμ m/z calc’d for [M + NH4]+ C16H20I2N 479.9680, found 479.9665. 
Phenyl(2-phenyloxazol-5-yl)methanone, 105: 
 
Synthesised according to the representative procedure for formation of 103 using 2,2'-diiodo-
4,4',6,6'-tetramethyl-1,1'-biphenyl (15.7 mg, 0.034 mmol, 0.2 equiv) instead of iodobenzene, 
to end up with 105 (0.014 g, 33%) as a brown solid. 
Melting point: 130-133 °C. 
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IR(neat): 3129 (w), 2916 (w), 2848 (w), 1648 (m) cm-1. 
1H NMR (400 MHz, CDCl3): δ 7.54 (5H, m), 7.66 (1H, t, J = 7.2 Hz), 7.88 (1H, s), 8.01 (2H, 
d, J = 7.7 Hz), 8.21 (2H, d, J = 7.1 Hz).  
13C NMR (100 MHz, CDCl3): δ 126.6, 127.9, 129.1, 129.3, 129.4, 132.3, 133.6, 137.3, 138.0, 
149.3, 165.2, 181.8. 
MS:  m/z (M + 1) 250.1. 
HRMSμ m/z calc’d for [M + H]+ C16H12NO2 250.0863, found 250.0790. 
N-(2, 2-Dimethylpropyne) benzamide, 106a:77 
 
In a round bottom flask dimethylpropargyl amine (0.96 mL, 9.1 mmol, 1 equiv) was dissolved 
in DCM (10 mL). Then, benzoylchloride (2 mL, 17.2 mmol, 1.89 equiv) and triethyl amine 
(2.54 mL, 18.2 mmol, 2 equiv) were added. The mixture was stirred and left overnight under 
a nitrogen atmosphere. A saturated solution of NaCl was added (10 mL) and the mixture 
extracted with DCM (10 mL x 2); the organic layers were combined and dried with anhydrous 
magnesium sulfate, filtered and concentrated under vacuum to give 106a as a light yellow 
solid (1.65g, 97%). 
Melting point: 153-155 °C. 
IR(neat): 3284 (w), 3239 (w), 3062 (w), 2979 (w), 2930 (w), 1714 (w) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.75 (6H, s), 2.38 (1H, s), 6.40 (1H, s), 7.38 (2H, t, J = 7.2 
Hz), 7.38 (1H, t, J = 7.1 Hz), 7.75 (2H, d, J = 7.1 Hz).  
13C NMR (100 MHz, CDCl3): δ 29.1, 31.0, 48.0, 69.6, 87.3, 126.9, 128.8, 131.6, 166.6. 
MS:  m/z (M + 23) 210. 
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HRMSμ m/z calc’d for [M + Na]+ C12H13NNaO 210.0889, found 210.0899. 
4-Chloro-N-(1, 1-dimethylprop-2-ynyl) benzamide, 106b: 
 
Synthesised according to the representative procedure for formation of 106a using 4-
chlorobenzoylchloride (1.5 mL, 11.4 mmol, 1.89 equiv) instead of benzoylchloride, to end up 
with 106b (1.22 g, 92%) as a white solid. 
Melting point: 146-149 °C. 
IR(neat): 3328 (w), 3284 (m), 2990 (w), 1644 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.76 (6H, s), 2.40 (1H, s), 6.15 (1H, s), 7.40 (2H, d, J = 8.5 
Hz), 7.70 (2H, d, J = 8.5 Hz). 
13C NMR (100 MHz, CDCl3): δ 29.3, 48.5, 69.9, 87.3, 128.7, 129.1, 133.5, 138.1, 165.7. 
MS:  m/z (M + 23) 244.0. 
HRMSμ m/z calc’d for [M + Na]+ C12H12ClNNaO 244.0500, found 244.0489. 
N-(1, 1-Dimethylprop-2-ynyl)-4-methoxy-benzamide, 106c: 
 
Synthesised according to the representative procedure for formation of 106a using 4-
methoxybenzoylchloride (1.5 mL, 11.4 mmol, 1.89 equiv) instead of benzoylchloride, to 
provide 106c (1.30g, 99 %.) as a white solid. 
Melting point: 87-91 °C. 
IR(neat): 3280 (w), 3271 (w), 2975 (w), 2934 (w), 1638 (s) cm-1. 
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1H NMR (400 MHz, CDCl3): δ 1.78 (6H, s), 2.41 (1H, s), 3.87 (3H, s), 6.14 (1H, s), 6.93 (2H, 
d, J = 8.8), 7.745 (2H, d, J = 8.8).77 
13C NMR (100 MHz, CDCl3): δ 36.9, 52.1, 55.6, 71.2, 85.9, 113.8, 127.3, 128.8, 162.1, 166.2. 
MS:  m/z (M + 23) 240.1. 
HRMSμ m/z calc’d for [M + Na]+ C13H15NNaO2 240.0995, found 240.0995. 
N-(2-Methylbut-3-yn-2-yl)-4-nitrobenzamide, 106d: 
 
Synthesised according to the representative procedure for formation of 106a using 4-
nitrobenzoylcholoride (2.12 g, 11.4 mmol, 1.89 equiv) instead of benzoylchloride, to provide 
106d as a yellow solid (0.54, 39 %). 
Melting point: 123-127 °C. 
IR(neat): 3278 (w), 2980 (m), 2184 (w), 1520 (m), 1343 (m) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.77 (6H, s), 2.42 (1 H, s), 6.29 (1H, s), 7.91 (2H, d, J = 7.7 
Hz), 8.26 (2H, d, J = 7.1 Hz). 
13C NMR (100 MHz, CDCl3): δ 29.2, 48.9, 70.3, 86.9, 124.2, 128.5, 140.7, 150.0, 164.8. 
MS:  m/z (M + 23) 255.1. 
HRMSμ m/z calc’d for [M + Na]+ C12H12N2NaO3 255.0740, found 255.0741. 
N-(1-Ethynylcyclohexyl)benzamide, 106e:77 
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In a round bottom flask 1-ethylcyclohexylamine (50 mg, 0.405 mmol, 1 equiv) was dissolved 
in 1 mL of DMF. Then, benzoylchloride (114 mg, 0.81 mmol, 2 equiv) and triethylamine (82 
mg, 0.81 mmol, 2 equiv) were added. The mixture was stirred and heated at 50 °C for an 
hour. Then the mixture was left stirring at room temperature overnight under a nitrogen 
atmosphere. The mixture was concentrated then purified by flash chromatography (5:1 
petroleum ether 40-60/EtOAc with 5% Et3N on silica) to give N-(1-
ethynylcyclohexyl)benzamide as a light brown solid (0.066 g, 72 %). 
Melting point: 114-119 °C. 
IR(neat): 3287 (w), 2980 (w), 2934 (w), 1638 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.60-2.27 (10H, m), 2.89 (1H, s), 6.13 (1H, s), 7.43 (2H, t, J 
=7.84 Hz), 7.51 (1H, t, J = 7.14 Hz), 7.78 (2H, d, J = 7.2 Hz).  
13C NMR (100 MHz, CDCl3): δ 22.7, 25.3, 37.2, 52.1, 71.7, 58.7, 127.1, 128.8, 131.8, 135.2, 
166.6. 
MS:  m/z (M + 23) 250.1. 
HRMSμ m/z calc’d for [M + Na]+ C15H17NNaO 250.1202, found 250.1202. 
N-(1-Ethynylcyclohexyl)-4-choloro-benzamide, 106f: 77 
 
Synthesised according to the representative procedure for formation of 106e using 4-
cholorobenzoylchloride (568.1 mg, 3.25 mmol, 2 equiv) instead of benzoylchloride, to 
provide 106f (0.294 g, 69 %.) as a white solid. 
Melting point: 133-136 °C. 
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IR(neat): 3296 (m), 2971 (w), 2294 (w), 2851 (w), 1643 (m) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.59-2.28 (10H, m), 2.47 (1H, s), 6.22 (1H, s), 7.37 (2H, d, J 
= 8.8 Hz), 7.71 (2H, d, J = 8.7 Hz).  
13CNMR (100 MHz, CDCl3): δ 22.7, 25.3, 36.9, 52.3, 71.7, 85.4, 128.3, 128.7, 133.3, 137.6, 
166.2. 
MS:  m/z (M + 23) 284.1. 
HRMSμ m/z calc’d for [M + Na]+ C15H16ClNNaO 284. 0813, found 284.0813. 
N-(1-Ethynylcyclohexyl)-4-methoxy-benzamide, 106g:77 
 
Synthesised according to the representative procedure for formation of 106e using 4-
methoxybenzoylchloride (276.4 mg, 1.62 mmol, 2 equiv) instead of benzoylchloride, to afford 
106g (0.193, 93 %.) as a light yellow solid. 
Melting point: 106-109 °C. 
IR(neat): 3305 (w), 3286 (w), 2931 (m), 2850 (w), 1642 (m) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.29-2.26 (10H, m), 2.47 (1H, s), 3.89 (3H, s), 6.14 (1H, s), 
6.89 (2H, d, J = 8.7 Hz), 7.74 (2H, d, J = 8.8 Hz).  
13CNMR (100 MHz, CDCl3)μ δ 22.5, 25.3, 36.9, 52.1, 55.6, 71.2, 85.9, 113.8, 127.3, 128.8, 
162.1, 166.2. 
MS:  m/z (M + 23) 280.1 
HRMSμ m/z calc’d for [M + Na]+  C16H19NNaO2 280. 1308, found 280.1308. 
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N-(1-Ethynylcyclohexyl)-4-nitrobenzamide, 106h: 
 
Synthesised according to the representative procedure for formation of 106e using 4-
nitrobenzoylcholoride (0.3 g, 1.62 mmol, 2 equiv) instead of benzoylchloride, to end up with 
106h (0.219 g, 99%) as a light yellow solid. 
Melting point: 137-140 °C. 
IR(neat): 3301 (w), 3244 (w), 2939 (w), 2853 (w), 1648 (s), 1522 (s), 1486 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.21-1.33 (1H, m), 1.58-1.74 (5H, m), 1.83-1.89 (2H, m), 
2.12-2.24 (2H, m), 2.45 (1H, s), 6.37 (1H, s), 7.88 (2H, d, J =  8.6 Hz), 8.19 (2H, d, J = 8.6 
Hz). 
13C NMR (100 MHz, CDCl3): δ 22.9, 25.5, 37.2, 53.0, 72.5, 85.1, 124.1, 128.5, 140.9, 149.9, 
164.7. 
MS:  m/z (M + 23) 295.1. 
HRMSμ m/z calc’d for [M + Na]+ C15H16N2NaO3 295.1053, found 295. 1053. 
N-(1,1-Dimethylprop-2-ynyl)-1H-indole-2-carboxamide, 106i:75  
 
Dimethylpropargyl amine (0.22 mL, 2.1 mmol, 1 equiv) was dissolved in CHCl3 (10 mL). 
Then, 1H-indole-2-carbonyl chloride (0.165 g, 9.3 mmol, 4.4 equiv) and triethylamine (0.59 
mL, 4.2 mmol, 2 equiv) were added. The mixture was stirred overnight under a nitrogen 
atmosphere. NaOH (3 M, 5 mL) was added and the mixture extracted with CH2Cl2 (10 mL x 
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2). The organic layers were combined and dried with anhydrous magnesium sulfate, filtered 
and concentrated under vacuum. The product was purified by flash chromatography (9:1 
petroleum ether 40-60 /EtOAc on silica) to give N-(1,1-dimethylprop-2-ynyl)-1H-indole-2-
carboxamide as a white solid (0.08g, 17 %). 
Melting point: 192-194 °C. 
IR(neat): 3273 (w), 2980 (w), 1638 (w), 1538 (m) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.81 (6H, s), 2.42 (1H, s), 6.25 (1H, s), 6.82 (1H, d, J = 1.60 
Hz), 7.14 (1H, t, J = 7. 7 Hz), 7.29 (1H, t, J = 7.6 Hz), 7.49 (1H, d, J = 8.2 Hz), 7.64 (1H, d, J 
= 8.1 Hz), 9.58 (1H, s).  
13C NMR (100 MHz, CDCl3): δ 29.3, 48.0, 69.7, 86.9, 102.0, 112.1, 120.7, 121.9, 124.5, 
127.6, 130.8, 136.4, 160.8. 
MS:  m/z (M + 23) 249.1. 
HRMSμ m/z calc’d for [M + Na]+ C14H14N2NaO 249.0998, found 249.0998. 
3-Bromo-N-(1,1-dimethylprop-2-ynyl)thiophene-2-carboxamide, 106j: 
 
Thionyl chloride (0.22 mL, 2.93 mmol, 3.4 equiv) was added to 3-bromothiophene-2-
carboxylic acid (0.165 g, 0.80 mmol, 2 equiv) in CHCl3 (3 mL). The mixture was stirred 
overnight. Then, the solvent was removed under vacuum to provide 3-bromothiophene-2-
carbonyl chloride. Then, dimethylpropargylamine (0.22 mL, 2.1 mmol, 1 equiv) dissolved in 
CHCl3 (10 mL) was added to the 3-bromothiophene-2-carbonyl chloride (0.165 g, 0.73 mmol, 
0.35 equiv). Triethylamine (0.59 mL, 4.2 mmol, 2 equiv) was added to the mixture and stirred 
overnight under a nitrogen atmosphere. NaOH (3 M, 5 mL) was added and the mixture 
extracted with DCM (10 mL x 2); the organic layers were combined and dried with anhydrous 
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magnesium sulfate, filtered and concentrated under vacuum. The product was purified by 
flash chromatography (5:1 petroleum ether 40-60 /EtOAc on silica) to give N-(1,1-
dimethylprop-2-ynyl)-1H-indole-2-carboxamide as an orange oil (0.596 g, 23 %). 
IR(neat): 3399 (w), 3295 (w), 3082 (w), 2979 (w), 1647 (s), 1517 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.69 (6H, s), 2.34 (1H, s), 6.95 (1H, d, J = 5.2 Hz), 7.17-7.25 
(1H, m), 7.37 (1H, d, J = 5.2 Hz). 
13C NMR (100 MHz, CDCl3): δ 29.4, 48.6, 70.0, 86.9, 108.7, 130.6, 132.3, 135.9, 159.6. 
MS:  m/z (M + 23) 293.9. 
HRMSμ m/z calc’d for [M + Na]+ C10H10NNaOS 293.9558, found 293.9559. 
N-(1,1-Dimethylprop-2-ynyl)-2-(2-thienyl)acetamide, 106k: 
 
Synthesised according to the representative procedure for formation of 106j using thionyl-3-
acetic acid (0.165 g, 1.16 mmol, 2 equiv), to give 106k (0.23 g, 53%) as a yellow solid. 
Melting point: 143-145 °C. 
IR(neat): 3304 (m), 3203 (m), 3009 (w), 2984 (w), 2935 (w), 1640 (s), 1548 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.57 (6H, s), 2.30 (1H, s), 3.55 (2H, s), 5.49 (1H, s), 6.99 (1H, 
dd, J = 5.1, 4.8 Hz), 7.13 (1H, d, J = 2.38 Hz), 7.32 (1H, dd, J = 3.0, 4.9 Hz). 
13C NMR (100 MHz, CDCl3): δ 29.2, 39.2, 48.0, 69.6, 87.3, 123.7, 127.1, 128.7, 135.2, 169.9. 
MS:  m/z (M + 23) 230.1. 
HRMSμ m/z calc’d for [M + Na]+ C11H13NNaOS 230.0611, found 230.0615. 
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N-(1,1-Dimethylprop-2-ynyl)furan-2-carboxamide, 106l:77 
 
Synthesised according to the representative procedure for formation of 106a using 2-furyl 
chloride (1.24 g, 9.5, 2 equiv), to end up with 106l (0.67 g, 73%) as a light yellow solid. 
Melting point: 101-104 °C. 
IR(neat): 3304 (w), 3278 (w), 3116 (w), 1646 (s), 1591 (s), 1528 (s), 1470 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.74 (6H, s), 2.38 (1H, s), 6.43 (1H, s), 6.48 (1H, dd, J = 3.48, 
3.47 Hz), 7.10 (1H, dd, J = 3.50, 3.48 Hz), 7.40 (1H, dd, J = 1.76, 1.67 Hz).  
13C NMR (100 MHz, CDCl3): δ 29.4, 48.0, 69.7, 87.1, 112.5, 114.6, 144.0, 148.4, 157.7. 
MS:  m/z (M + 23) 200.1. 
HRMSμ m/z calc’d for [M + Na]+ C10H11NNaO2 200.0682, found 200.0679. 
N-(2-Methylbut-3-yn-2-yl)-2-phenylacetamide, 106m: 
 
Synthesised according to the representative procedure for formation of 106j using phenyl 
acetic acid (1.7 g, 11.4 mmol, 2 equiv) and dimethylpropargyl amine (0.6 mL, 5.7 mmol, 1 
equiv), to give 106m (0.69 g, 61%) as a yellow solid. 
Melting point: 144-147 °C. 
IR(neat): 3311 (m), 3206 (m), 3064 (w), 2995 (w), 2935 (w), 1640 (s), 1541 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.59 (6H, s), 2.32 (1H, s), 3.55 (2H, s), 5.52 (1H, s), 7.27-7-39 
(5H, m).77 
13C NMR (100 MHz, CDCl3): δ 29.1, 44.7, 47.9, 69.4, 87.2, 127.6, 129.3, 129.6, 135.1, 170.3. 
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MS:  m/z (M + 23) 224.1. 
HRMSμ m/z calc’d for [M + Na]+ C13H15NNaO 224.1046, found 224.1045. 
N-(2-methylbut-3-yn-2-yl)benzamide-d1, 106n: 
 
N-(2,2-Dimethylpropyne)benzamide 106a (0.2 g, 1.06 mmol, 1 equiv.) was dissolved in 
MeCN (1 mL) and K2CO3 (0.22 g, 1.59 mmol, 1.5 equiv.) was added to the mixture. After 30 
min of stirring, D2O (0.96 mL, 53 mmol, 50 equiv.) was added and the mixture was stirred 
overnight at rt. The mixture was extracted with DCM (10 mL × 2) and the organic layers were 
combined and dried with anhydrous magnesium sulfate, filtered and concentrated under 
vacuum. The residue was stirred with HCl (0.5 M, 2 mL) for 7 days, and then extracted with 
DCM (10 mL × 2). The organic layers were combined and dried with anhydrous magnesium 
sulfate, filtered and concentrated under vacuum to give the product (0.132g, 66%) as white 
solid. 
Melting point: 155-158 °C. 
IR(neat): 3485 (w), 3238 (w), 2980 (w), 2583 (w), 1639 (s), 1514 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.77 (6H, s), 6.13 (1H, s), 7.40–7.70 (3H, m), 7.75 (2H, d, J = 
7.1 Hz). 
13C NMR (100 MHz, CDCl3): δ 29.4, 48.4, 61.8, 86, 127.2, 128.9, 131.9, 135.2, 166.8. 
MS:  m/z (M + 23) 211.1. 
HRMSμ m/z calc’d for [M + Na]+ C12H12DNNaO 211.0952, found 211.0959. 
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N-(2-Methylbut-3-yn-2-yl)acetamide, 106o:75 
 
Synthesised according to the representative procedure for formation of 106a using acetyl 
chloride (0.71 mL, 10.01 mmol, 1 equiv), to provide 106o as a colourless oil (0.40 g, 35%). 
IR(neat): 3263 (s), 3076 (w), 2983 (w), 1945 (s), 1548 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.57 (6H, s), 1.98 (3H, s), 2.35 (1H, s), 5.68 (1H, s).  
13C NMR (100 MHz, CDCl3): δ 24.1, 28.9, 47.5, 69.1, 87.2, 169.2. 
MS:  m/z (M + 23) 148.1. 
HRMSμ m/z calc’d for [M + Na]+ C7H11NNaO 148.0733, found 148.0732. 
N-(2-Methylbut-3-yn-2-yl)benzenesulfonamide, 106p: 
 
1,1-dimethylpropargyl amine (0.96 mL, 9.1 mmol, 1 equiv) was dissolved in 10 mL of DCM. 
Then, benzenesulfonyl chloride (1.28 mL, 10.01 mmol, 1.1 equiv) was added followed by 
Et3N (2.45 mL, 18.2 mmol, 2 equiv) and DMAP (10 mg). The mixture was stirred over night 
under nitrogen atmosphere. Saturated salt of NaCl was added then extracted by DCM (2 x 10 
mL) the organic layers were combined and dried with anhydrous magnesium sulfate, filtered 
and concentrated under vacuum. The mixture was purified by flash chromatography (5:1 
petroleum ether 40-60 /EtOAc on silica) to give the product as a yellow oil (1.3 g, 63 %). 
IR(neat): 3248 (m), 2986 (w), 2359 (w), 2344 (w), 1448 (m), 1320 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.58 (6H, s), 2.08 (1H, s), 4.91 (1H, s), 7.51 (2H, t, J = 7.8 
Hz), 7.58 (1H, t, J = 7.1 Hz), 7.94 (2H, d, J = 7.3 Hz). 
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13C NMR (100 MHz, CDCl3): δ 30.7, 49.9, 71.3, 85.2, 127.7, 128.7, 132.5, 141.6. 
MS:  m/z (M + 23) 246.1. 
HRMSμ m/z calc’d for [M + Na]+ C11H13NNaO2S 246.0559, found 246. 0559. 
N-(1-(Phenylethynyl)cyclohexyl)benzamide, 109: 
 
1-Ethynylcyclohexylamine (100 g, 0.81 mmol, 1 equiv) was dissolved in Et3N (5 mL) then 
CuI (16 mg, 0.081 mmol, 10 mol%), PhI (91 ȝL, 0.81 mmol, 1 equiv) and Pd(PPh3)4 (5 mg, 
0.040 mmol, 0.5 mol%) were added. The mixture was left stirring overnight at room 
temperature then concentrated under reduced pressure. The residue was purified by flash 
chromatography (5 : 1 : 0.005 petroleum ether/EtOAc/Et3N on silica gel) to provide the 
product as a brown oil (0.064 g, 45%). This was dissolved in DMF (5 mL) then 
benzoylchloride (84 ȝL, 0.72 mmol, 2 equiv) and Et3N (101 ȝL, 0.72 mmol, 2 equiv) were 
added. The mixture was stirred overnight and concentrated under reduced pressure. The 
residue was purified by flash chromatography (5 : 1 petroleum ether 40-60/EtOAc on silica 
gel) to provide the product as a white solid (0.096 g, 84%). 
Melting point: 174–177 °C. 
IR(neat): 3285 (w), 3050 (w), 2913 (w), 2851 (w), 1786 (w), 1639 (s) cm− 1. 
1H NMR (400 MHz, CDCl3)μ δ 1.30–1.39 (1H, m), 1.63–1.83 (5H, m), 2.08–2.22 (2H, m), 
2.26–2.29 (2H, m), 6.22 (1H, s), 7.27–7.29 (3H, m), 7.40–7.50 (5 H, m), 7.77 (2 H, d, J = 7.3 
Hz). 
13C NMR (100 MHz, CDCl3)μ δ 23.3, 25.7, 37.3, 53.6, 84.2, 91.4, 123.5, 127.3, 128.4, 128.5, 
128.9, 131.7, 132.2, 135.7, 166.7. 
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MS:  m/z (M + 23) 326.1. 
HRMSμ m/z calc’d for [M + Na]+ C21H21NNaO 326.1515, found 326.1508. 
E-chalcone and N-(3-oxo-1,3-diphenylpropyl)benzamide, 117, 118 : 
 
In an oven-dried sealed tube benzamide (0.5 g, 4.13 mmol, 1 equiv) and Cu(OTf)2 (0.15 g, 
0.413 mmol, 0.1 equiv) were dissolved in toluene (5 mL). Then benzaldehyde (0.46 mL, 5.54 
mmol, 1.1 equiv) was added, followed by phenylacetylene (0.68 mL, 6.2 mmol, 1.5 equiv). 
The tube was flushed with nitrogen then sealed. The mixture was stirred and heated at 100 °C 
for four days. Then, HCl (3M aq, 5 mL) was added to the mixture and it was extracted with 
Et2O, and then sat aq NaHCO3 (5 mL) was added to the organic layer and extracted with Et2O 
(2 x 5 mL). The organic layers were combined and dried with anhydrous magnesium sulfate, 
filtered and concentrated under vacuum. The product was purified by flash chromatography 
(20:1 petroleum ether 40-60 /EtOAc on silica), and E-chalcone 117 was collected before N-
(3-oxo-1,3-diphenylpropyl)benzamide 118 in the column tubes. 
E-chalcone, 117:62 light brown solid (0.36 g, 42%). 
Melting point: 59-62 °C. 
IR(neat): 3024 (w), 1662 (m),1604 (s), 1574 (m) cm−1. 
1H NMR (400 MHz, CDCl3): 7.38-7.41 (3H, m), 7.47-7.50 (2H, m), 7.54-7.58 (2H, m), 7.60-
7.64 (2H, m), 7.84 (1H, d, J = 16 Hz), 8.04-8.06 (2H, m).  
13C NMR (100 MHz, CDCl3)μ δ 122.2, 128.6, 128.7, 128.8, 129.1, 130.7, 132.9, 135.0, 138.3, 
144.9, 190.5. 
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MS:  m/z (M + 23) 231.1. 
HRMS: m/z calc’d for [M + Na]+ C14H12NaO 231.0780, found 231.0780. 
N-(3-Oxo-1,3-diphenylpropyl)benzamide, 118: yellow solid (0.61 g, 45%). 
Melting point: 154-158 °C. 
IR(neat): 3302 (w), 3059 (w), 1681(m), 1634 (s), 1578 (w), 1532 (m) cm−1. 
1H NMR (400 MHz, CDCl3)μ δ 3.42 (1H, dd, J = 6.0, 17.2 Hz), 3.80 (1H, dd, J = 6.2, 17.1 
Hz), 5.77-5.81 (1H, m), 7.18-7.23 (5 H, m), 7.32-7.49 (5H, m), 7.48 (1H, t, J = 7.4 Hz), 7.80 
(2H, d, J = 8.0 Hz), 7.84 (2H, d, J = 8.0 Hz), 8.04 (1H, s). 
13Cμ δ 43.4, 50.5, 126.7, 127.3, 127.6, 128.4, 128.7, 128.8, 128.9, 131.7, 133.7, 134.5, 136.8, 
141.4, 167.0, 199.1. 
MS:  m/z (M + 23) 352.1. 
HRMSμ m/z calc’d for [M + Na]+ C22H19NNaO2 352.1308, found 352.1308. 
4, 4-Dimethyl-5-methylene-2-phenyl-4,5-dihydrooxazole, 107a:77 
 
In a round bottom flask N-(2, 2-dimethylpropyne)benzamide (50 mg, 0.27 mmol, 1 equiv) 
(106a) was dissolved in DCM (5 mL). Then, copper iodide (15.2 mg, 10 mol%) was added 
and the mixture was stirred at room temperature overnight. The product was purified by flash 
chromatography (5:1 petroleum ether 40-60 /EtOAc on silica) to give 4,4-dimethyl-5-
methylene-2-phenyl-4,5-dihydrooxazole a yellow oil (0.37g, 73%). 
IR(neat): 2972 (w), 2971 (w), 2294 (w), 2851 (w), 1643 (m) cm-1. 
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1H NMR (400 MHz, CDCl3): δ 1.47 (6H, s), 4.26 (1H, d, J = 2.9 Hz), 4.76 (1H, d, J = 2.9 
Hz), 7.42-7.46 (2H, m), 7.49-7.55 (1H, m), 7.99-8.02 (2H, m).  
13C NMR (100 MHz, CDCl3): δ 29.8, 69.1, 82.4, 127.1, 128.1, 128.5, 131.8, 160.0, 168.1. 
MS:  m/z (M+1) 188.1. 
HRMSμ m/z calc’d for [M + H]+ C12H14NO 188.1070, found 188.1069. 
2-(4-Chloro-phenyl)-4,4-dimethyl-5-methylene-4,5-dihydrooxazole, 107b: 
 
4-Chloro-N-(1,1-dimethylprop-2-ynyl)benzamide (50 mg, 0.226 mmol, 1 equiv) (106b) was 
dissolved in DCE (2 mL), and then CuI was added (5 mg, 0.0226 mmol, 0.1 equiv). The 
mixture was heated under reflux overnight at 80 °C. The product was purified by flash 
chromatography (5:1 petroleum ether 40-60 /EtOAc on silica) to provide 107b as a yellow oil 
(0.044g, 88%). 
IR(neat): 2974 (w), 2928 (w), 1674 (m), 1309 (s) cm-1.  
1H NMR (400 MHz, CDCl3): δ 1.47 (6H, s), 4.28 (1H, d, J = 2.8 Hz), 4.76 (1H, d, J = 2.8 
Hz), 7.42 (2H, d, J = 8.6 Hz), 7.94 (2H, d, J = 8.6 Hz). 
13C NMR (100 MHz, CDCl3): δ 30.1, 69.6, 83.2, 125.6, 129.2, 129.8, 138.4, 159.6, 167.9. 
MS:  m/z (M+1) 222.1. 
HRMSμ m/z calc’d for [M + H]+ C12H13ClNO 222.0680, found 222.0680. 
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2-(4-Methoxy-phenyl)-4,4-dimethyl-5-methylene-4,5-dihydrooxazole, 107c: 
 
Synthesised according to the representative procedure for formation of 107b using N-(1,1-
dimethylprop-2-ynyl)-4-methoxy-benzamide (100 mg, 0.46 mmol, 1 equiv) 106c, to end up 
with 107c as a colourless oil (0.093 g, 93 %). 
IR(neat): 2972 (w), 2930 (w), 1643 (m), 1609 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.44 (6H, s), 3.84 (3H, s), 4.22 (1H, d, J = 2.7 Hz), 4.71 (1H, 
d, J = 2.7 Hz), 6.92 (2H, d, J = 9.0 Hz), 7.93 (2H, d, J = 9.0 Hz). 
13C NMR (100 MHz, CDCl3): δ 30.2, 55.7, 69.3, 82.3, 114.2, 119.7, 130.2, 160.0, 162.7, 
168.4. 
MS:  m/z (M + 23) 240.1. 
HRMSμ m/z calc’d for [M + Na]+ C13H15NNaO2 240.0995, found 240.0995.  
2-(4-Nitro-phenyl)-4,4-dimethyl-5-methylene-4,5-dihydrooxazole, 107d: 
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Synthesised according to the representative procedure for formation of 107b using N-(1, 1-
dimethylprop-2-ynyl)-4-methoxy-benzamide (20 mg, 0.086 mmol, 1 equiv) 106d to end up 
with 107d as a yellow solid (0.0175 g, 88 %). 
Melting point: 103–107 °C. 
IR(neat): 3108 (w), 2974 (w), 1679 (m), 1644 (m), 1524 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.46 (6H, s), 4.31 (1H, d, J = 3.0 Hz), 4.78 (1H, d, J = 3.1 
Hz), 8.15 (2H, d, J = 8.9 Hz), 8.28 (2H, d, J = 9.0 Hz). 
13C NMR (100 MHz, CDCl3): δ 30.0, 70.0, 83.9, 124.0, 129.5, 133.2, 150.0, 158.6, 167.7. 
MS:  m/z (M + 1) 233.1. 
HRMSμ m/z calc’d for [M + H]+ C12H13N2O3 233.0921, found 233.0937.  
4-Methylene-2-phenyl-3-oxa-1-azaspiro[4.5]dec-1-ene, 107e:75  
 
Synthesised according to the representative procedure for formation of 107b using N-(1-
ethynylcyclohexyl)benzamide (100 mg, 0.44 mmol, 1 equiv) 106e, to provide 107e as a 
colourless oil (0.091 g, 91 %). 
IR(neat): 2929 (m), 2853 (w), 1650 (m), 1309 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.53-1.92 (10H, m), 4.26 (1H, d, J = 2.7), 4.76 (1H, d, J = 2.7 
Hz), 7.44 (2H, t, J = 7.2 Hz), 7.5 (1H, t, J = 7.1 Hz), 8.03 (2H, d, J = 7.1 Hz).  
13C NMR (100 MHz, CDCl3): δ 22.1, 39.3, 57.7, 72.3, 82.5, 127.4, 128.1, 128.4, 131.5, 159.3, 
168.4. 
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MS:  m/z (M + 1) 228.1. 
HRMSμ m/z calc’d for [M + H]+ C15H18NO 228.1383, found 228.1382. 
2-(4-Chlorophenyl)-4-methylene-3-oxa-1-azaspiro[4.5]dec-1-ene, 107f:77 
 
Synthesised according to the representative procedure for formation of 107b using N-(1-
ethynylcyclohexyl)-4-choloro-benzamide (50 mg, 0.226 mmol, 1 equiv) 106f, to provide 107f 
as a colourless oil (0.041 g, 82 %). 
IR(neat): 2929 (m), 2852 (w), 1654 (s), 1489 (m) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.47-1.89 (10H, m), 4.23 (1H, d, J = 2.8 Hz), 4.72 (1H, d, J= 
2.8 Hz), 7.38 (2H, d, J = 8.5 Hz), 7.91 (2H, d, J = 8.6 Hz). 
13C NMR (100 MHz, CDCl3): δ 22.5, 26.0, 39.5, 72.5, 83.2, 126.3, 129.1, 129.9, 138.0, 158.8, 
168.5. 
MS:  m/z (M + 1) 262.1. 
HRMSμ m/z calc’d for [M + H]+ C15H17ClNO 262.0993, found 262.0991. 
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2-(4-Methoxyphenyl)-4-methylene-3-oxa-1-azaspiro[4.5]dec-1-ene 107g: 
 
The synthesis was undertaken according to the representative procedure for formation of 107b 
but with N-(1-ethynylcyclohexyl)-4-methoxy-benzamide (50 mg, 0.226 mmol, 1 equiv) 106g 
to end up with 107g as a colourless oil (0.048 g, 99 %). 
IR(neat): 2929 (m), 2852 (w), 1646 (s), 1510 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.38-1.5 (10H, m), 3.84 (3H, s), 4.22 (1H, d, J = 2.4 Hz), 4.71 
(1H, d, J = 2.7 Hz), 6.92 (2H, t, J = 9.1 Hz), 7.95 (2H, d, J = 9.0 Hz). 
13C NMR (100 MHz, CDCl3): δ 22.5, 25.9, 39.5, 55.7, 72.1, 82.8, 114.1, 120.0, 130.2, 159.6, 
162.5, 168.6. 
MS:  m/z (M + 1) 258.1. 
HRMSμ m/z calc’d for [M + H]+ C16H20NO2 258.1488, found 258.1488.  
2-(4-Nitrophenyl)-4-methylene-3-oxa-1-azaspiro[4.5]dec-1-ene, 107h: 
 
  
 
124 
 
Synthesised according to the representative procedure for formation of 107b using N-(1,1-
dimethylprop-2-ynyl)-4-methoxy-benzamide (20 mg, 0.07 mmol, 1 equiv) 106h, to end up 
with 107h as a brown solid (0.017 g, 89 %). 
Melting point: 68–71°C. 
IR(neat): 3301 (w), 2932 (s), 2853 (m), 1708 (m) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.68-1.90 (10H, m), 4.29 (1H, d, J = 3.0 Hz), 4.78 (1H, d, J = 
3.0 Hz), 8.17 (2H, d, J = 8.7 Hz), 8.28 (2H, d, J = 9.7 Hz). 
13C NMR (100 MHz, CDCl3): δ 22.4, 25.9, 39.6, 73.0, 83.9, 123.9, 129.5, 133.6, 149.9, 157.9, 
168.2. 
MS:  m/z (M+1) 273.1. 
HRMSμ m/z calc’d for [M + H]+ C15H17N2O3 273.1234, found 273.1239. 
2-(1H-Indol-2-yl)-4,4-dimethyl-5-methylene-4,5-dihydrooxazole, 107i: 
 
Synthesised according to the representative procedure for formation of 107b but with N-(1,1-
dimethylprop-2-ynyl)-1H-indole-2-carboxamide (20 mg, 0.088 mmol, 1 equiv) 106i to end up 
with 107i as a colourless oil (0.017 g, 85 %). 
IR(neat): 3126 (w), 3066 (w), 2968 (m), 1698 (m), 1650 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.46 (6H, s), 4.29 (1H, d, J = 3.0 Hz), 4.78 (1H, d, J = 3.0 
Hz), 7.13 (1H, s), 7.25 (1H, d, J = 7.5 Hz), 7.29 (1H, d, J = 7.3 Hz), 7.38 (1H, d, J = 8.2 Hz), 
7.68 (1H, d, J = 8.0 Hz), 9.34 (1H, s). 
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13C NMR (100 MHz, CDCl3): δ 30.2, 69.2, 83.3, 107.3, 111.9, 121.0, 122.4, 124.8, 125.1, 
128.1, 137.5, 155.4, 167.7.  
MS:  m/z (M + 23) 227.1. 
HRMSμ m/z calc’d for [M + Na]+ C14H15N2O 227.1178, found 227.1186. 
2-(3-Bromothiophen-2-yl)-4,4-dimethyl-5-methylene-4,5-dihydrooxazole, 107j: 
 
Synthesised according to the representative procedure for formation of 107b using 3-bromo-
N-(1,1-dimethylprop-2-ynyl)thiophene-2-carboxamide (100 mg, 0.564 mmol, 1 equiv) (106j), 
to give 107j (0.259 g, 87%) as a brown oil. 
IR(neat): 3082 (w), 2973 (w), 2927 (w), 1696 (w), 1637 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.45 (6H, s), 4.25 (1H, d, J = 3.0 Hz), 4.75 (1H, d, J = 2.9 
Hz), 7.06 (1H, d, J = 5.3 Hz), 7.40 (1H, d, J = 5.3 Hz). 
13C NMR (100 MHz, CDCl3): δ 26.1, 30.1, 69.6, 83.3, 114.2, 129.8, 133.1, 154.9, 167.6. 
MS:  m/z (M + 23) 293.9. 
HRMSμ m/z calc’d for [M + Na]+ C10H10BrNNaOS 293.9558, found 293.9524. 
4,4-Dimethyl-5-methylene-2-(thiophen-2-ylmethyl)-4,5-dihydrooxazole, 107k: 
 
  
 
126 
 
Synthesised according to the representative procedure for formation of 107b using N-(1,1-
dimethylprop-2-ynyl)-2-(2-thienyl)acetamide (100 mg, 0.45 mmol, 1 equiv) (106k), to give 
107k (0.072 g, 77%) as a dark green oil. 
IR(neat): 3108 (w), 2972 (m), 2927 (w), 1667 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.35 (6H, s), 3.71 (2H, s), 4.15 (1H, d, J = 3.0 Hz), 4.57 (1H, 
d, J = 3.3 Hz), 7.04 (1H, d, J = 5.0 Hz), 7.16 (1H, d, J = 1.8 Hz), 7.28 (1H, d, J = 5.0 Hz). 
13C NMR (100 MHz, CDCl3): δ 29.8, 29.9, 69.0, 82.5, 123.0, 126.3, 128.5, 134.4, 162.0, 
168.4. 
MS:  m/z (M + 23) 208.1. 
HRMSμ m/z calc’d for [M + Na]+ C11H14NOS 208.0790, found 208.0789. 
(4,4-Dimethyl-5-methylene-oxazol-2-yl)-(2-thienyl)methanone, 107k`: 
 
4,4-Dimethyl-5-methylene-2-(thiophen-2-ylmethyl)-4,5-dihydrooxazole 107k (30 mg, 0.14 
mmol, 1 equiv.) was dissolved in 1,2-DCE (2 mL) and CuI was added (3 mg, 10 mol%). The 
mixture was heated at reflux overnight and then concentrated under vacuum. The residue was 
purified by flash chromatography (5 : 1 petroleum ether–EtOAc on silica gel) to provide the 
product 107k` as a yellow oil (18 mg, 58%). 
IR(neat): 2975 (w), 2930 (w), 2360 (w), 1671 (s), 1634 (m) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.48 (6H, s), 4.32 (1H, d, J = 3.2 Hz), 4.84 (1H, d, J = 2.9 
Hz), 7.33 (1H, dd, J = 5.2, 5.1 Hz), 7.81 (1H, dd, J = 5.2, 5.1 Hz), 8.90 (1H, dd, J = 2.9, 3.0 
Hz). 
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13C NMR (100 MHz, CDCl3): δ 27.7, 57.8, 95.3, 125.9, 127.5, 131.0, 136.1, 150.1, 154.0, 
158.1. 
MS:  m/z (M + 23) 244.0. 
HRMSμ m/z calc’d for [M + Na]+ C11H11NNaO2S 244.0402, found 244.0402. 
2-(Furan-2-yl)-4,4-dimethyl-5-methylene-4,5-dihydrooxazole, 107l: 
 
Synthesised according to the representative procedure for formation of 107b using N-(1,1-
dimethylprop-2-ynyl)furan-2-carboxamide (100 mg, 0.564 mmol, 1 equiv) (106l) to end up 
with 107l (0.076 g, 76%) as a brown oil. 
IR(neat): 3649 (w), 2981 (w), 2170 (w), 2156 (w), 2039 (m) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.26 (6H, s), 4.07 (1H, d, J = 3.1 Hz), 4.54 (1H, d, J = 3.0 
Hz), 6.32 (1H, dd, J = 3.4, 4.0 Hz), 6.82 (1H, d, J = 3.4 Hz), 7.38 (1H, d, J = 1.5 Hz). 
13C NMR (100 MHz, CDCl3): δ 29.7, 69.0, 83.0, 111.7, 115.0, 142.1, 145.7, 152.4, 167.2. 
MS:  m/z (M + 23) 200.1. 
HRMSμ m/z calc’d for [M + Na]+ C10H11NNaO2 200.0682, found 200.0689. 
 (4,4-Dimethyl-5-methylene-4,5-dihydrooxazol-2-yl)(phenyl)methanone, 107m: 
 
N-(2-Methylbut-3-yn-2-yl)-2-phenylacetamide 106m (50 mg, 0.25 mmol, 1 equiv) was 
dissolved in 1,2-DCE (2 mL) and CuI (5 mg, 10 mmol%) was added. The mixture was heated 
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at reflux for 48 h and then concentrated under vacuum. The residue was purified by flash 
chromatography (5 : 1 petroleum ether–EtOAc on silica gel) to provide the product 107m as a 
yellow solid (38 mg, 71%). 
Melting point: (53-56 °C). 
IR(neat): 2975 (w), 2930 (w), 2360 (w), 1671 (s), 1634 (m) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.50 (6H, s), 4.34 (1H, d, J = 3.4 Hz), 4.84 (1H, d, J = 3.1 
Hz), 7.47-7.51 (2H, m), 7.61-7.65 (1H, m), 8.28-8.31 (2H, m). 
13C NMR (100 MHz, CDCl3): δ 29.8, 70.9, 84.9, 128.9, 131.1, 134.8, 134.8, 155.9, 166.2, 
182.8. 
MS:  m/z (M + 23) 238.1. 
HRMSμ m/z calc’d for [M + Na]+ C13H13NNaO2 238.0838, found 238.0838. 
(Z)-4,4-dimethyl-5-(methylene-d)-2-phenyl-4,5-dihydrooxazole, 107na: 
 
Synthesised according to the representative procedure for formation of 107b using N-(2-
methylbut-3-yn-2-yl)benzamide-d1 (106n). 
1H NMR (400 MHz, CDCl3): δ 1.47 (6H, s), 4.23 (1H, s), 7.42-7.46 (2H, m), 7.49-7.55 (1H, 
m), 7.99-8.02 (2H, m).  
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(E)-4,4-dimethyl-5-(methylene-d)-2-phenyl-4,5-dihydrooxazole, 107nb: 
 
Synthesised according to the representative procedure for formation of 107b using N-(2-
methylbut-3-yn-2-yl)benzamide-d1 (106n). 
1H NMR (400 MHz, CDCl3): δ 1.47 (6H, s), 4.73 (1H, s), 7.42-7.46 (2H, m), 7.49-7.55 (1H, 
m), 7.99-8.02 (2H, m).  
4,4-Dimethyl-5-methylene-2-phenylthiazole, 119a : 
 
In a round bottom flask N-(2,2-dimethylpropyne)benzamide (200 mg, 1.068 mmol, 1 equiv) 
(106a) was added, and then Lawesson’s reagent (432 mg, 1.086 mmol, 1 equiv) was added. 
Then, dry toluene (10 mL) was added while the flask was under nitrogen atmosphere. The 
mixture was heated at 90 °C under reflux overnight. The product was purified by flash 
chromatography (5:1 petroleum ether 40-60 /EtOAc on silica) to give 4,4-dimethyl-5-
methylene-2-phenyl-thiazole as a yellow oil (0.115 g, 53 %).      
IR(neat): 2972 (m), 2927 (w), 1604 (m), 1447 (m) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.53 (6H, s), 5.18 (1H, d, J = 1.7 Hz), 5.27 (1H, d, J = 1.9 
Hz), 7.39-7.45 (3H, m), 7.77-7.80 (2H, m). 
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13C NMR (100 MHz, CDCl3): δ 29.8, 82.8, 103.2, 128.3, 128.9, 131.5, 133.5, 156.7, 160.1. 
MS:  m/z (M + 1) 203.1. 
HRMSμ m/z calc’d for [M + H]+ C12H14NS 203.0841, found 203.0853. 
2-(4-Chlorophenyl)-4,4-dimethyl-5-methylene-thiazole, 119b: 
 
Synthesised according to the representative procedure for formation of 119a using 4-chloro-
N-(1,1-dimethylprop-2-ynyl)benzamide (100 mg, 0.451 mmol, 1 equiv) 106b to provide 
1119b as a yellow oil (0.067 g, 63 %). 
IR(neat): 2973 (m), 2928 (w), 1606 (m), 1489 (m) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.50 (6H, s), 5.17 (1H, d, J = 1.6 Hz), 5.25 (1H, d, J = 1.6 
Hz), 7.34-7.38 (2H, m), 7.67-7.70 (2H, m). 
13C NMR (100 MHz, CDCl3): δ 29.7, 82.9, 103.5, 129.1, 129.6, 132.0, 137.6, 156.6, 159.6. 
MS:  m/z (M + 1) 238.0 
HRMSμ m/z calc’d for [M + H]+ C12H13ClS 238.0451, found 238.0459. 
2-(4-Methoxyphenyl)-4,4-dimethyl-5-methylene-thiazole, 119c: 
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Synthesised according to the representative procedure for formation of 119a using N-(1, 1-
dimethylprop-2-ynyl)-4-methoxy-benzamide (200 mg, 0.921 mmol, 1 equiv) 106c, to end up 
with 119c as a yellow oil (0.042 g, 20%). 
IR(neat): 2971 (m), 2929 (w), 2837 (w), 1605 (s), 1509 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.53 (6H, s), 3.86 (3H, s), 5.18 (1H, d, J = 1.3 Hz), 5.27 (1H, 
d, J = 1.7 Hz), 6.91-6.94 (2H, m), 7.72-7.75 (2H, m). 
13C NMR (100 MHz, CDCl3): δ 29.7, 55.5, 82.4, 102.7, 113.9, 126, 129.7, 156.8, 160.2, 
162.1. 
MS:  m/z (M + 1) 234.1 
HRMSμ m/z calc’d for [M + H]+ C13H16NOS 234.0947, found 234.0947. 
N-(1-Ethylcyclohexyl)benzamide, 120: 
 
4,4-Dimethyl-5-methylene-2-phenyl-4,5-dihydrooxazole 107a (40 mg, 0.22 mmol, 1 equiv) 
and Pd/C (11.7 mg, 0.011 mmol, 0.05 equiv) were mixed with EtOAc under a nitrogen 
atmosphere, and then a balloon of H2 was used to replace the nitrogen with H2, and the 
mixture was left stirring overnight. The product was purified by flash chromatography (9:1 
petroleum ether 40-60 /EtOAc on silica) to give N-(1-ethylcyclohexyl)benzamide as a white 
solid (0.029 g, 57 %). 
IR(neat): 2922 (m), 2363 (m), 2163 (m), 2027 (s), 2019 (s), 1636 (s), 1525 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 0.77 (3H, t, J =7.6 Hz), 1.17-1.61 (10 H, m), 1.85 (2H, q, J = 
7.6 Hz), 5.61 (1H, s), 7.33-7.43 (3H, m), 7.65-7.68 (2H, m). 
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13C NMR (100 MHz, CDCl3): δ 7.8, 22.0, 25.9, 30.7, 34.9, 56.6, 127.2, 128.5, 131.4, 136.3, 
167.0.  
MS:  m/z (M + 23) 254.2. 
HRMSμ m/z calc’d for [M + Na]+ C15H21NNaO 254. 1515, found 254.1515. 
5-(Iodomethylene)-4,4-dimethyl-2-phenyl-4,5-dihydrooxazole, 126: 
 
4,4-Dimethyl-5-methylene-2-phenyl-4,5-dihydrooxazole 107a ( 50 mg 0.27 mmol, 1 equiv)  
was dissolved in acetone (2 mL), then NIS (153 mg, 0.68 mmol, 2.5 equiv) and K2CO3 (37 
mg, 0.27 mmol, 1 equiv) were added to the mixture which was left stirring overnight at room 
temperature. The mixture was quenched by addition of saturated aqueous Na2S2O3 and 
extracted with EtOAc (2 x 5 mL). The combined organic layers were dried with anhydrous 
magnesium sulfate, filtered and concentrated under vacuum, to provide 126 as a yellow oil 
(0.84 g, 99%). 
IR(neat): 3065 (w), 2977 (w), 2928 (w), 1710 (w), 1669 (s), 1637 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.61 (6H, s), 5.68 (1H, s), 7.34 (2H, t, J =  7.5 Hz), 7.42(1H, t, 
J =  7.5 Hz), 7.86 (2H, d, J =  7.5 Hz). 
13C NMR (100 MHz, CDCl3): δ 46.0, 71.1, 125.7, 127.0, 128.3, 128.6, 132.2, 159.1, 163.0. 
MS:  m/z (M + 23) 236.1. 
HRMSμ m/z calc’d for [M + Na]+ C12H12INNaO 235. 9856, found 236.0010. 
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N-Allylbenzamide, 127a:67 
 
In a round bottom flask allylamine (0.65 mL, 8.8 mmol, 1 equiv) was dissolved in DCM(10 
mL). Then, benzoyl chloride (1.12 mL, 9.68 mmol, 1.1 equiv) and triethylamine (3 mL, 19.36 
mmol, 2 equiv) were added. The mixture was stirred overnight under a nitrogen atmosphere. 
Then, NaOH solution (1 M, 10 mL) was added, and the mixture extracted with DCM (10 mL 
x 2); the organic layers were combined and dried with anhydrous magnesium sulfate, filtered 
and concentrated under vacuum to give a colourless oil  (1.40 g, 98%). 
IR(neat): 3277 (w), 3050 (w), 2981 (w), 2971 (w), 2234 (w), 2181 (m), 2153 (m), 1994 (m), 
1633 (m), 1530 (m)  cm-1. 
1H NMR (400 MHz, CDCl3): δ 4.06-4.09 (2H, m), 5.16-5.27 (2H, m), 5.87-5.97 (1H, m), 6.35 
(1H, s), 7.39-7.43 (2H, m), 7.47-7.51 (1H, m), 7.77-7.79 (2H, m).  
13C NMR (100 MHz, CDCl3): δ 41.8, 112.4, 114.5, 116.9, 134.2, 144.2, 148.2, 158.6. 
MS:  m/z (M + 1) 162.0. 
HRMSμ m/z calc’d for [M + H]+ C10H12NO 162.0913, found 162.0919. 
N-Allyl-4-chlorobenzamide, 127b: 
 
Synthesised according to the representative procedure for formation of 127a using 4-
chlorobenzoyl chloride (1.1 mL, 9.68 mmol, 1.1 equiv). The product was purified by flash 
chromatography (5:1 petroleum ether 40-60 /EtOAc) to end up with 127b (1.55g, 90%) as a 
white solid. 
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Melting point: 77-80 °C. 
IR(neat): 3280 (w), 3062 (w), 1631 (m), 1593 (m), 1532 (m) cm-1. 
1H NMR (400 MHz, CDCl3): δ 4.06-4.09 (2H, m), 5.18-5.28 (2H, m), 5.88-5.97 (1H, m), 6.15 
(1H, s), 7.40 (2H, d, J = 8.4 Hz), 7.70-7.73 (2H, m). 
13C NMR (100 MHz, CDCl3): δ 42.9, 117.3, 128.7, 129.2, 133.2, 134.3, 138.1, 166.6. 
MS:  m/z (M + 1) 196.0. 
HRMSμ m/z calc’d for [M + H]+ C10H11ClNO 196.0524, found 196.0525. 
N-Allyl-4-methoxybenzamide, 127c:67 
 
Synthesised according to the representative procedure for formation of 127a using 4-
methoxybenzoyl chloride (1.30 mL, 9.68 mmol, 1.1 equiv). The product was purified by flash 
chromatography (3:1 petroleum ether 40-60 /EtOAc) to end up with 127c (1.10g, 66%) as a 
white solid. 
Melting point: 56-58 °C. 
IR(neat): 3328 (w), 3064 (w), 1627 (m), 1605 (m), 1542 (m), 1504 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 3.83 (3H, s), 4.05-4.08 (2H, m), 5.15-5.26 (2H, m), 5.88-5.97 
(1H, m), 6.15 (1H, s), 6.89-6.93 (2H, m), 7.72-7.76 (2H, m).  
13C NMR (100 MHz, CDCl3): δ 42.7, 55.8, 114.1, 116.9, 127.0, 129.1, 134.7, 162.5, 167.3. 
MS:  m/z (M + 1) 192.1. 
HRMSμ m/z calc’d for [M + H]+ C11H14NO2 192.1019, found 192.1020. 
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N-Allyl-4-nitrobenzamide, 127d: 
 
Synthesised according to the representative procedure for formation of 127a using 4-
nitrobenzoyl chloride (1.53 g, 9.68 mmol, 1.1 equiv). The product was purified by flash 
chromatography (3:1 petroleum ether 40-60 /EtOAc) to end up with 127d (1.81g, 99%) as a 
yellow solid. 
Melting point: 120-124 °C. 
IR(neat): 3367 (w), 3232 (w), 1645 (m), 1597 (m), 1524 (m) cm-1. 
1H NMR (400 MHz, CDCl3): δ 4.08-4.12 (2H, m), 5.20-5.30 (2H, m), 5.88-5.98 (1H, m), 6.38 
(1H, s), 7.92-7.96 (2H, m), 8.26-8.29 (2H, m).78 
13C NMR (100 MHz, CDCl3): δ 43.1, 117.7, 124.2, 128.5, 133.8, 140.4, 149.9, 165.7. 
MS:  m/z (M + 1) 207.1. 
HRMSμ m/z calc’d for [M + H]+ C10H11N2O3 207.0764, found 207.0770. 
N-Allylfuran-2-carboxamide, 127e; 
 
Synthesised according to the representative procedure for formation of 127a using 2-
fuorylchloride (0.95 g, 9.68 mmol, 1.1 equiv) to end up with 127e (1.35 g, 93%) as dark green 
oil. 
IR(neat): 3317 (w), 1651 (w), 1592 (m), 1570 (w) cm-1. 
1H NMR (400 MHz, CDCl3): δ 3.99-4.01 (2H, m), 5.11-5.23 (2H, m), 5.81-5.91 (1H, m), 
6.44-6,46 (1H, m), 6.59 (1H, s), 7.07 (1H, d, J = 3.2), 7.39 (1H, s).79 
  
 
136 
 
13C NMR (100 MHz, CDCl3): δ 41.7, 112.3, 114.5, 116.8, 134.2, 144.2, 148.1, 158.6. 
MS:  m/z (M + 1) 152.1. 
HRMSμ m/z calc’d for [M + H]+ C8H10NO2 152.0706, found 152.0707. 
4-Methoxy-N-(2-methylallyl)benzamide, 127f: 
 
Synthesised according to the representative procedure for formation of 127a using 2-methyl-
2-propen-1-amine (0.25 g, 3.52 mmol, 1 equiv) and 4-methoxybenzoyl chloride (0.59 mL, 3.9 
mmol, 1.1 equiv). The product was purified by flash chromatography (5:1 petroleum ether 40-
60 /EtOAc) to end up with 127f (0.65 g, 90%) as a white solid. 
Melting point: 92-96 °C. 
IR(neat): 3337 (w), 3084 (w), 2979 (w), 1629 (m), 1606 (s), 1544 (m) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.79 (3H, s), 3.85 (3H, s), 4.01 (2H, d, J = 5.9 Hz), 4.87-4.90 
(2H, m), 6.11 (1H, s), 6.91-6.95 (2H, m), 7.74-7.77 (2H, m). 
13C NMR (100 MHz, CDCl3): δ 20.9, 45.8, 55.8, 111.4, 114.2, 127.2, 129.1, 142.6, 162.6, 
167.2. 
MS:  m/z (M + 1) 206.1. 
HRMSμ m/z calc’d for [M + H]+ C12H16NO2 206.1176, found 206.1175. 
N-(1-(Cyclohex-1-en-1-yl)ethyl)-4-methoxybenzamide, 127g: 
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Synthesised according to the representative procedure for formation of 127a using (1-
cyclohex-1-en-1-ylethyl)amine hydrochloride (0.25 g, 1.55 mmol, 1 equiv) and 4- 
methoxybenzoyl chloride (0.25 mL, 1.87 mmol, 1.1 equiv) to end up with 127g (0.332 g, 
83%) as a light yellow solid. 
Melting point: 118-120 °C. 
IR(neat): 3343 (w), 2980 (w), 2970 (w), 2925 (m), 1630 (m), 1608 (m), 1498 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.32 (3H, d, J = 6.8 Hz), 1.55-1.66 (4H, m), 1.95-2.08 (4H, 
m), 3.84 (3H, s), 4.56-4.63 (1H, m), 5.68 (1H, d, J = 1.0 Hz), 5.91 (1H, d, J = 7.8 Hz), 6.90-
6.94 (2H, m), 7.71-7.75 (2H, m). 
13C NMR (100 MHz, CDCl3): δ 19.9, 22.8, 23.1, 25.4, 26.3, 50.5, 55.8, 114.1, 121.9, 127.6, 
129.0, 138.9, 162.4, 166.5. 
MS:  m/z (M + 1) 260.2. 
HRMSμ m/z calc’d for [M + H]+ C16H22NO2 260.1645, found 260.1648. 
N-(Furan-2-ylmethyl)-4-methoxybenzamide, 127h:80 
 
Synthesised according to the representative procedure for formation of 127a using 
furfurylamine (0.5 mL, 5.15 mmol, 1 equiv) and 4-methoxybenzoyl chloride (0.8 mL, 5.7 
mmol, 1.1 equiv). The product was purified by flash chromatography (1:1 petroleum ether 40-
60 /EtOAc) to end up with 127h (0.78 g, 66%) as a light brown solid. 
Melting point: 112-126 °C. 
IR(neat): 3307 (w), 3140 (w), 3106 (w), 1621 (s), 1607 (s), 1573 (w), 1542 (m) cm-1. 
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1H NMR (400 MHz, CDCl3): δ 3.83 (3H, s), 4.62 (2H, d, J = 5.5 Hz), 6.28 (1H, d, J = 3.2 
Hz), 6.32-6.34 (2H, m), 6.86-6.92 (2H, m), 7.36 (1H, s), 7.72-7.76 (2H, m).  
13C NMR (100 MHz, CDCl3): δ 37.3, 55.8, 107.9, 110.9, 114.1, 126.8, 129.2, 142.6, 151.7, 
162.6, 167.0. 
MS:  m/z (M + 1) 232.1. 
HRMSμ m/z calc’d for [M + H]+ C13H14NO3 232.0968, found 232.0973. 
 
N-Allyl-2-methylbenzamide, 129a:81 
 
In a round bottom flask o-toluic acid (0.4 g, 3 mmol, 1 equiv) was dissolved in chloroform 
(10 mL). Then, thionyl chloride (0.44 mL, 6 mmol, 2 equiv) was added and the mixture was 
stirred overnight at room temperature. Then, the solvent was removed, and allylamide (0.8 
mL, 11 mmol, 1 equiv) in DCM (10 mL) was added to the mixture followed by triethylamine 
(2 mL, 22 mmol, 2 equiv). The mixture was stirred and left overnight under a nitrogen 
atmosphere. Then, NaOH solution (1 M, 10 mL) was added, and the mixture extracted with 
DCM (10 mL x 2); the organic layers were combined and dried with anhydrous magnesium 
sulfate, filtered and concentrated under vacuum to give a yellow solid  (0.28 g, 15%). 
Melting point: 67-70 °C. 
IR(neat): 3280 (w), 2980 (w), 2926 (w), 1638 (m), 1534 (m) cm-1. 
1H NMR (400 MHz, CDCl3): δ 2.34 (3H, s), 3.94 (2H, s), 5.07-5.20 (2H, m), 5.78-5.87 (1H, 
m), 5.97 (1H, s), 7.07-7.13 (2H, m), 7.19-7.26 (2H, m).  
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13C NMR (100 MHz, CDCl3): δ 20.1, 42.4, 116.8, 125.9, 126.9, 130.1, 131.3, 134.4, 136.3, 
136.6, 170.3. 
MS:  m/z (M + 1) 176.1. 
HRMSμ m/z calc’d for [M + H]+ C11H14NO 176.1070, found 176.1067. 
N-Allyl-2-phenylacetamide, 129b:82 
 
Synthesised according to the representative procedure for formation of 129a using 
phenylacetic acid (0.4 g, 3 mmol, 1 equiv) to end up with 129b (0.19 g, 10%) as a white solid. 
Melting point: 66-69 °C. 
IR(neat): 3239 (w), 3063 (w), 1658 (m), 1625 (m), 1555 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 3.61 (2H, s), 3.84 (2H, t, J = 5.7 Hz), 5.02-5.07 (2H, m), 5.39 
(1H, s), 5.71-5.81 (1H, m), 7.28-7.38 (5H, m).  
13C NMR (100 MHz, CDCl3): δ 42.2, 44.1, 116.4, 127.7, 129.4, 129.8, 134.3, 135.2, 171.2. 
MS:  m/z (M + 1) 176.1. 
HRMSμ m/z calc’d for [M + H]+ C11H14NO 176.1070, found 176.1070. 
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Methyl 2-(4-methoxybenzamido)cyclopent-3-enecarboxylate, 131: 
  
Thionylchloride (0.075 mL, 1.023 mmol, 1.1 equiv) was added dropwise to dry methanol (10 
mL) at 0 °C. Then, cis-2-amino-3-cyclopentene-1-carboxylic acid hydrochloride (0.150 g, 
0.93 mmol, 1 equiv) was added and the mixture was stirred overnight under a nitrogen 
atmosphere at 66 °C. Then, the solvent was removed, and 4-methoxybenzoyl chloride (0.13 
mL, 0.94 mmol, 1.1 equiv) in DCM (10 mL) was added to the mixture followed by 
triethylamine (0.21 mL, 2.55 mmol, 2 equiv). The mixture was stirred overnight under a 
nitrogen atmosphere. Then, NaOH solution (1 M, 10 mL) was added, and the mixture 
extracted with DCM (10 mL x 2); the organic layers were combined and dried with anhydrous 
magnesium sulfate, filtered and concentrated under vacuum. The product was purified by 
flash chromatography (20:1 petroleum ether 40-60 /EtOAc) to end up with 131 (0.19 g, 81%) 
as a yellow solid. 
Melting point: 66-69 °C. 
IR(neat): 3288 (w), 2981 (w), 1731 (m), 1628 (m), 1605 (m),1574 (w)  cm-1. 
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1H NMR (400 MHz, CDCl3): δ 2.61 (1H, dd, J = 8.9, 17.3 Hz), 2.84-2.91 (1H, m), 3.49 (1H, 
dd, J = 8.7, 15.2 Hz), 3.59 (3H, s), 3.83 (3H, s), 5.57 (1H, t, J = 9.2 Hz), 5.69 (1H, dd, J = 2.0, 
5.1), 5.97 (1H, d, J = 3.2 Hz), 6.35 (1H, d, J = 8.7 Hz), 6.90 (2H, d, J = 8.7 Hz), 7.70 (2H, d, J 
= 8.3 Hz). 
13C NMR (100 MHz, CDCl3): δ 35.4, 45.9, 52.3, 55.7, 56.5, 114.1, 126.9, 129.1, 130.2, 133.8, 
162.6, 166.5, 174.6. 
MS:  m/z (M + 1) 276.1. 
HRMSμ m/z calc’d for [M + H]+ C15H18NO4 276.1230, found 276.1235. 
4-Methoxy-N-(2-phenylallyl)benzamide, 133:83 
 
In a round bottom flask α-methylstyrene (5 g, 42 mmol, 1 equiv) was dissolved in 15 mL of 
CCl4. Then, N-bromosuccinimide (4.7 g, 26.25 mmol, 0.625 equiv) was added, and the 
mixture was stirred overnight under reflux. The mixture was cooled in an ice-water bath and 
CCl4 was removed, and then, phthalimide (3.4 g, 23.2 mmol, 0.8 equiv) in DMF (20 mL) was 
added to the mixture followed by K2CO3 (8 g, 58 mmol, 2 equiv) and the mixture was stirred 
overnight at 60 °C. Brine (10 mL) was added to the mixture which was extracted with EtOAc 
(10 mL x 2). The organic layers were combined and dried with anhydrous magnesium sulfate, 
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filtered and concentrated under vacuum. Then, phthalimide product was dissolved in 
petroleum ether (40-60 °C) and hydrazine hydrate (0.98 mL, 31.4 mmol, 2 equiv) was added. 
The mixture was stirred for 15 minutes; the solid was collected by vacuum filtration and 
washed by Et2O. The solid was placed in a conical flask and a mixture of DCM/HCl (1:1) was 
added and stirred for 15 minutes. This was filtered to remove any solid materials. The liquid 
partition was placed in a separatory funnel and extracted with HCl (6 M). The aqueous layers 
were combined and basified by slow addition of solid KOH at °C, and then extracted with 
Et2O (10 mL x 3). The organic layers were combined and dried with anhydrous magnesium 
sulfate filtered and concentrated under vacuum to give 0.148 g of the amine product. 4-
Methoxybenzoyl chloride (0.17 mL, 1.22. 1.1 equiv) and Et3N (0.19 mL, 2.22 mmol, 2 equiv) 
were added to the amine product in DCM (10 mL), and stirred overnight under nitrogen. 
NaOH solution (2 M) was added, and the mixture extracted with DCM (5 mL x 3). The 
organic layers were combined and dried with anhydrous magnesium sulfate filtered and 
concentrated under vacuum to give the product as a yellow solid (0.204 g, 69%).  
Melting point: 158-161°C. 
IR(neat): 3311 (w), 3006 (w), 1639 (m), 1628 (m), 1603 (s) cm-1. 
1H NMR (400 MHz, CDCl3): δ 3.83 (3H, s), 4.53 (2H, d, J = 5.7 Hz), 5.32 (1H, s), 5.52 (1H, 
s), 6.10 (1H, s), 6.89 (2H, m), 7.33 (3H, m), 7.48 (2H, m), 7.68 (2H, m).  
13C NMR (100 MHz, CDCl3): δ 44.1, 55.8, 114.1, 114.4, 126.5, 127.0, 128.5, 129.0, 129.1, 
138.7, 144.7, 162.6, 167.2. 
MS:  m/z (M + 1) 268.1. 
HRMSμ m/z calc’d for [M + H]+ C17H18NO2 268.1336, found 268.1334. 
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Methyl 2-(cyclohexa-1,4-dien-1-yl)-2-(4-methoxybenzamido)acetate, 134: 
 
Synthesised according to the representative procedure for formation of 131 using (R)-(−)-2-
(2,5-dihydrophenyl)glycine (1 g, 6.5 mmol, 1 equiv) to end up with 134 (0.508 g, 34%) as a 
white solid. 
Melting point: 132-135 °C. 
IR(neat): 3273 (w), 2952 (w), 2822 (m), 1733 (m), 1636 (s), 1609 (m), 1578 (m) cm-1. 
1H NMR (400 MHz, CDCl3): δ 2.65-2.79 (4H, m), 3.79 (3H, s), 3.85 (3H, s), 5.18 (1H, d, J = 
7.4 Hz), 5.64-5.71 (2H, m), 5.86 (1H, s), 6.77 (1H, d, J = 7.4 Hz), 6.91- 6.94 (2H, m), 7.76-
7.80 (2H, m). 
13C NMR (100 MHz, CDCl3): δ 26.7, 27.1, 53.1, 55.8, 58.2, 114.1, 123.8, 124.1, 124.7, 126.4, 
129.3, 130.9, 162.8, 166.6, 171.9. 
MS:  m/z (M+1) 302.1. 
HRMSμ m/z calc’d for [M + H]+ C17H20NO4 302.1387, found 302.1393. 
N-(2-Vinylphenyl)benzamide, 135:70 
 
In a round bottom flask 2-vinylaniline (1 g, 8.4 mmol, 1 equiv) was dissolved in DCM (15 
mL). Then, benzoyl chloride (1.17 mL, 10.08 mmol, 1.2 equiv) and 4-dimethylaminopyridine 
(1.23 g, 10.08 mmol, 1.2 equiv) were added and the mixture was stirred overnight at room 
temperature under a nitrogen atmosphere. Then, HCl (3 M, 10 mL) and brine were added, and 
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the mixture extracted with DCM (10 mL x 2). The organic layers were combined and dried 
with anhydrous magnesium sulfate, filtered and concentrated under vacuum to give a light 
brown solid (1.58 g, 84%). 
Melting point: (152-155 °C). 
IR(neat): 3225 (w), 2981 (w), 2354 (w), 1647 (s), 1600 (w) cm-1. 
1H NMR (400 MHz, CDCl3): δ 5.47 (1H, d, J = 11.0 Hz), 5.72 (1H, d, J = 17.5 Hz), 6.68 (1H, 
dd, J = 11.1, 17.4 Hz), 7.20 (1H, t, J = 7.6 Hz), 7.33-7.37 (1H, m), 7.49-7.52 (3H, m), 7.55-
7.59 (1H, m), 7.87-7.90 (3H, m), 8.04 (1H, d, J = 8.0 Hz).  
13C NMR (100 MHz, CDCl3): δ 119.9, 123.8, 125.8, 127.4, 127.4, 127.5, 129.0, 129.2, 130.9, 
132.3, 132.7, 134.8, 135.1. 
MS:  m/z (M + 1) 224.1. 
HRMSμ m/z calc’d for [M + H]+ C15H14NO 224.1070, found 224.1066. 
(2-Phenyl-4,5-dihydrooxazol-5-yl)methanol, 128a: 
 
In a round bottom flask 127a (0.2 g, 1.24 mmol, 1 equiv) was dissolved in acetonitrile (10 
mL). Then, 2-iodoanisole (0.0034 mL, 0.248 mmol, 0.2 equiv) was added, followed by 
trifluoroacetic acid (0.19 mL, 2.48 mmol, 2 equiv) and Selectflour (0.44 g, 1.24 mmol, 1.24 
equiv). The mixture was stirred overnight at room temperature. Then, NaOH solution (3 M, 
10 mL) was added, and the mixture extracted with DCM (10 mL x 2); the organic layers were 
combined and dried with anhydrous magnesium sulfate, filtered and concentrated under 
vacuum. The product was purified by flash chromatography (1:1 petroleum ether 40-60 
/EtOAc) to end up with 128a (0.138 g, 63%) as a light brown solid. 
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Melting point: 88-90 °C. 
IR(neat): 3203 (br), 2921 (br), 2859 (w), 1718 (w), 1644 (s), 1601 (w) cm-1. 
1H NMR (400 MHz, CDCl3): δ 2.76 (1H, br), 3.71 (1H, dd, J = 12, 6.2 Hz), 3.78-3.87 (1H, 
m), 3.82 (1H, d, J = 15 Hz), 4.07 (1H, dd, J = 15, 10 Hz), 4.76-4.85 (1H, m), 7.39 (2H, d, J = 
7.7 Hz), 7.47 (1H, t, J = 7.7 Hz), 7.93 (2H, d, J = 7.7 Hz).  
13C NMR (100 MHz, CDCl3): δ 56.7, 64.5, 80.5, 127.8, 128.5, 128.7, 131.8, 164.4. 
MS:  m/z (M + 1) 178.1. 
HRMSμ m/z calc’d for [M + H]+ C10H12NO2 178.0863, found 178.0865. 
(2-(4-Chlorophenyl)-4,5-dihydrooxazol-5-yl)methanol, 128b: 
 
Synthesised according to the representative procedure for formation of 128a using 127b (0.2 
g, 1.05 mmol, 1 equiv). The product was purified by flash chromatography (1 : 3 petroleum 
ether 40-60 /EtOAc) to end up with 128b (0.153 g, 69%) as a yellow solid. 
Melting point: 159-161 °C. 
IR(neat): 3181 (br), 2913 (br), 1642 (m), 1621 (s), 1596 (w) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.89 (1H, s), 3.73 (1H, dd, J = 12, 6.0 Hz), 3.79-3.90 (2H, m), 
4.10 (1H, dd, J = 15, 10 Hz), 4.79-4.88 (1H, m), 7.39 (2H, d, J = 8.4 Hz), 7.88 (2H, d, J = 8.4 
Hz). 
13C NMR (100 MHz, CDCl3): δ 56.8, 64.7, 80.7, 126.4, 129.7, 129.9, 138.0, 163.4. 
MS:  m/z (M + 1) 212.0 
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HRMSμ m/z calc’d for [M + H]+ C10H11ClNO2 212.0473, found 212.0475. 
(2-(4-Methoxyphenyl)-4,5-dihydrooxazol-5-yl)methanol, 128c: 
 
Synthesised according to the representative procedure for formation of 128a using 127c (0.2 
g, 1.05 mmol, 1 equiv). The product was purified by flash chromatography (1:3 petroleum 
ether 40-60 /EtOAc) to end up with 128c (0.171 g, 79%) as a bright yellow solid. 
Melting point: 124-127 °C. 
IR(neat): 3172 (br), 3171 (w), 2980 (s), 2888 (w), 1649 (m) cm-1. 
1H NMR (400 MHz, CDCl3): δ 1.85 (1H, br), 3.72 (1H, dd, J = 12, 6.4 Hz), 3.76-3.89 (2H, 
m), 3.85 (3H, s), 4.08 (1H, dd, J = 15, 10 Hz), 4.76-4.85 (1H, m), 6.91 (2H, d, J = 8.7 Hz), 
7.88 (2H, d, J = 8.7 Hz).  
13C NMR (100 MHz, CDCl3): δ 55.7, 56.6, 64.6, 80.4, 113.7, 114.1, 120.3, 130.3, 162.5. 
MS:  m/z (M + 1) 208.1 
HRMSμ m/z calc’d for [M + H]+ C11H14ClNO3 208.0968, found 208.0972. 
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(2-(4-Nitrophenyl)-4,5-dihydrooxazol-5-yl)methanol, 128d: 
 
Synthesised according to the representative procedure for formation of 128a using 127d (0.1 
g, 0.49 mmol, 1 equiv). The product was purified by flash chromatography (1:5 petroleum 
ether 40-60 /EtOAc) to end up with 128d (0.068 g, 64%) as a yellow solid. 
Melting point: 113-117 °C. 
IR(neat): 3363 (br), 3071 (w), 2946 (w), 1645 (m), 1521 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.97 (1H, s), 3.76 (1H, dd, J = 5.7, 12.3 Hz), 3.88-3.94 (2H, 
m), 4.16 (1H, dd, J = 10.0, 15.2 Hz), 4.86-4.93 (1H, m), 8.16 (2H, d, J = 8.8 Hz), 8.26 (2H, d, 
J = 8.9 Hz). 
13C NMR (100 MHz, CDCl3): δ 57.0, 64.4, 81.1, 123.7, 129.6, 133.7, 149.9, 162.5. 
MS:  m/z (M+1) 223.1 
HRMSμ m/z calc’d for [M + H]+ C10H11N2O4 223.0713, found 223.0716. 
(2-(Furan-2-yl)-4,5-dihydrooxazol-5-yl)methanol, 128e: 
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Synthesised according to the representative procedure for formation of 128a using 127e (0.1 
g, 0.66 mmol, 1 equiv). The product was purified by flash chromatography (1:5 petroleum 
ether 40-60 /EtOAc) to end up with 128e (0.087 g, 79%) as a brown solid. 
Melting point: 100-103 °C. 
IR(neat): 3220 (br), 3113 (w), 2962 (w), 2916 (w), 1671 (s), 1562 (w) cm-1. 
1H NMR (400 MHz, CDCl3): δ 2.20 (1H, s), 3.72 (1H, dd, J = 12, 6.0 Hz), 3.82-3.86 (2H, m), 
4.09 (1H, dd, J = 15, 10 Hz), 4.77-4.84 (1H, m), 6.48 (1H, s), 6.96 (1H, d, J = 3.3 Hz), 7.53 
(1H, s). 
13C NMR (100 MHz, CDCl3): δ 56.5, 64.1, 80.8, 111.9, 114.9, 143.1, 145.6, 1568. 
MS:  m/z (M+1) 168.1 
HRMSμ m/z calc’d for [M + H]+ C8H10NO3 168.0655, found 168.0656. 
(2-(4-Methoxyphenyl)-5-methyl-4,5-dihydrooxazol-5-yl)methanol, 128f:84 
 
Synthesised according to the representative procedure for formation of 128a using 127f (0.2 
g, 0.98 mmol, 1 equiv). The product was purified by flash chromatography (1:3 petroleum 
ether 40-60 /EtOAc) to end up with 128f (0.189 g, 81%) as a brown oil. 
IR(neat): 3234 (br), 2980 (w), 2931 (w), 1638 (s), 1607 (s) cm-1. 
1H NMR (400 MHz, CDCl3)μ δ 1.41 (3H, s), 2.84 (1H, s), 3.56-3.71 (3H, m), 3.82 (3H, s), 4.0 
(1H, d, J =  14.5 Hz), 6.85-6.88 (2H, m), 7.82-7.85 (2H, m).  
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13C NMR (100 MHz, CDCl3): δ 22.8, 55.7, 62.6, 67.9, 86.4, 114.0, 120.6, 130.2, 162.5, 163.4. 
MS:  m/z (M + 1) 222.1 
HRMSμ m/z calc’d for [M + H]+ C12H16NO3 222.1125, found 222.1128. 
(2-(o-Tolyl)-4,5-dihydrooxazol-5-yl)methanol, 130: 
 
Synthesised according to the representative procedure for formation of 128a using 129a (0.22 
g, 1.26 mmol, 1 equiv). The product was purified by flash chromatography (1:1 petroleum 
ether 40-60 /EtOAc) to end up with 130 (0.173 g, 72%) as a yellow oil. 
IR(neat): 3271 (br), 2928 (w), 2871 (w), 1639 (s) cm-1. 
1H NMR (400 MHz, DMSO-d6): δ 2.54 (3H, s), 3.49-3.56 (1H, m), 3.57-3.64 (1H, m), 3.78 
(1H, dd, J = 7.5, 15.0 Hz), 3.98 (1H, dd, J = 10, 15 Hz),  4.64-4.72 (1H, m), 5.05 (1H, t, J = 
5.5 Hz), 7.25-7.32, (2H, m), 7.40 (1H ,td, J = 7.5, 1.4 Hz), 7.76 (1H, dd, J = 1.2, 7.7 Hz).  
13C NMR (100 MHz, DMSO-d6): δ 22.8, 55.9, 63.9, 80.3, 126.9, 128.5, 130.7, 131.7, 132.4, 
139.4, 164.3. 
MS:  m/z (M + 1) 192.1 
HRMSμ m/z calc’d for [M + H]+ C11H14NO2 192.1019, found 192.1019. 
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Methyl 6-hydroxy-2-(4-methoxyphenyl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]oxazole-
4-carboxylate, 132: 
 
Synthesised according to the representative procedure for formation of 128a using 131 (0.1 g, 
0.4 mmol, 1 equiv). The product was purified by flash chromatography (1:1 petroleum ether 
40-60 /EtOAc) to end up with 137 (0.062 g, 53%) as a light brown solid. 
Melting point: 159-162 °C. 
IR(neat): 3215 (br), 2945 (w), 2846 (w), 1730 (m), 1638 (m), 1607 (m) cm-1. 
1H NMR (400 MHz, CDCl3): 1.31 (1H, s), 1.85-2.0 (2H, m), 3.44-3.50 (1H, m), 3.79 (3H, s), 
3.83 (3H, s), 4.39 (1H, d, J = 3.5 Hz), 4.82 (1H, d, J = 7.1 Hz), 5.03 (1H, t, J = 7.3 Hz), 6.90 
(2H, d, J = 8.5 Hz), 7.82 (2H, d, J = 8.5 Hz).  
13C NMR (100 MHz, CDCl3): δ 33.1, 47.8, 52.3, 55.7, 72.5, 75.9, 88.4, 113.9, 119.8, 130.7, 
162.6, 164.2, 172.5. 
MS:  m/z (M + 1) 292.1 
HRMSμ m/z calc’d for [M + H]+ C15H18NO5 292.1179, found 292.1179. 
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